Top

Brian D. Badgwell, MD

Department of Surgical Oncology, Division of Surgery

About Dr. Badgwell

Dr. Badgwell is a graduate of Texas A&M University and also received his M.D. degree from Scott & White Hospital/Texas A&M. He subsequently completed a General Surgery Residency at The Ohio State University Medical Center, and received additional postgraduate training as a research fellow while at Ohio State through The Arthur G. James Cancer Hospital and Research Institute. Dr. Badgwell is a graduate of our University of Texas, MD Anderson Surgical Oncology Fellowship Program. While a fellow in surgical oncology, Dr. Badgwell simultaneously earned a Master’s degree in Epidemiology from the University of Texas School Of Public Health.

Dr. Badgwell has a cancer-directed practice in gastric and gastroesophageal cancer at MD Anderson that incorporates recent progress in advanced laparoscopic surgery and intraperitoneal chemotherapy in the treatment of patients with gastric cancer. He has worked tirelessly to improve outcomes for the most common site of metastatic disease and site of recurrence in gastric cancer – the peritoneum – through clinical trials of hyperthermic intraperitoneal perfusion with chemotherapy (HIPEC). Dr. Badgwell performed the first laparoscopic HIPEC at MD Anderson and now serves as a national and international referral source for the surgical treatment of gastric cancer metastatic to the peritoneum. His multidisciplinary group is aggressively investigating many aspects of intraperitoneal chemotherapy, and Dr. Badgwell has performed over 100 HIPEC procedures for gastric cancer, which is the largest single surgeon experience for this disease in the United States. He was the principal investigator for the first three completed trials of HIPEC for gastric cancer in the United States, and performed all surgeries for the patients on these trials. Dr. Badgwell is continuously exploring new options of intraperitoneal therapy, which has kept MD Anderson at the forefront of surgical options for patients with metastases to the peritoneum

It is also remarkable to find a surgical oncologist dedicated to the important clinical problem of palliative care for patients with advanced malignancy requiring surgical evaluation for problems related to their cancer. Dr. Badgwell has established a palliative surgery research program at MD Anderson and, with funding through the American Cancer Society, has developed the first validated symptom assessment questionnaire for patients with malignant bowel obstruction. As a recognized expert in surgery to improve the quality of life for patients with advanced cancer, Dr. Badgwell takes a leadership role in the teaching and mentoring of trainees. As a Professor of Surgery at MD Anderson, Dr. Badgwell has published over 100 peer-reviewed manuscripts and also leads the gastric cancer surgical research program at MD Anderson. He is consistently recognized for his excellent clinical care and high patient satisfaction scores.

Meet Brian Badgwell, M.D.

Present Title & Affiliation

Primary Appointment

Hamill Foundation Distinguished Professorship in Honor of Dr. Richard G. Martin, Sr, Division of Surgery, The University of Texas MD Anderson Cancer Center

Professor, Tenure, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2008	The University of Texas School of Public Health, Houston, Texas, US, Epidemiology, Minor: Biostatistics, M.S
1999	Texas A&M University, College Station, Texas, US, MD
1995	Texas A&M University, College Station, Texas, US, Biomedical Science, BS

Postgraduate Training

2005-2008	Clinical Fellowship, Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
2001-2002	Research Fellowship, Surgical Oncology, The Arthur G. James Cancer Hospital and Research Institute, Columbus, Ohio
2000-2005	Clinical Residency, General Surgery, The Ohio State University Medical Center, Columbus, Ohio
1999-2000	Clinical Internship, General Surgery, The Ohio State University Medical Center, Columbus, Ohio

Licenses & Certifications

2005	Texas State Medical License

Experience & Service

Faculty Academic Appointments

Associate Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2019

Assistant Professor, University of Arkansas for Medical Sciences, Little Rock, AR, 2008 - 2012

Administrative Appointments/Responsibilities

Director, AstraZeneca Advanced Scientific Workshop, “Management of Resectable and Advanced Gastric/GEJ Adenocarcinoma”, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present

Chief, Department of Peritoneal, and Acute Care Surgical Oncology, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2023

Program Subcommittee Member-Stomach, Society of Surgery of the Alimentary Tract, Beverly, MA, 2018 - 2019

Clinical Director, Infusion Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2016

Acute Care Proceduralist Program Clinical Medical Director and Mobile Procedure Team, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2016

Member, Commission on Cancer State Chair for Arkansas, Little Rock, AR, 2011 - 2012

Clinical Medical Director, Department of Winthrop P. Rockefeller Cancer Institute, Surgical Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, 2011 - 2012

Cancer Liaison Physician, Department of Surgery, Central Arkansas Veterans Healthcare System, American College of Surgeons, Commission on Cancer, Little Rock, AR, 2010 - 2011

Coordinator, Department of Melanoma Medical Oncology, Disease Oriented Committee, Little Rock, AR, 2010 - 2012

Extramural Institutional Committee Activities

Chief, Section of Gastric, Peritoneal, and Acute Care Surgical Oncology, The University of Texas MD Anderson Cancer Center, 2020 - 2023

Member, Faculty Appeals Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

Member, Data and Safety Monitoring Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2020

Member, Scientific Review Committee # 2 (SRC 2), The University of Texas MD Anderson Cancer Center, 2019 - 2023

Member, Peri-Procedure Anticoagulant Algorithm Workgroup, The University of Texas MD Anderson Cancer Center, 2014 - 2016

Member, Division of Surgery, Promotions & Tenure Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present

Member, Clinical Research Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2018

Program Co-Chair, Gastrointestinal Medical Oncology Multidisciplinary Gastric Cancer Conference, The University of Texas MD Anderson Cancer Center, 2013 - Present

Committee Member, Patient-Reported Outcomes, Survey & Population Research Shared Advisory Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2015

Member, Pharmacy & Therapeutic Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2015

Clinical Director, Infusion Therapy, The University of Texas MD Anderson Cancer Center, 2012 - 2016

Clinical Medical Director and Mobile Procedure Team, Acute Care Proceduralist, The University of Texas MD Anderson Cancer Center, 2012 - 2016

Editorial Activities

Section Editor, Gastrointestinal Cancer, Annals of surgical oncology, 2025 - Present

Editorial Board, Annals of Surgical Oncology - Gastrointestinal Oncology Section, 2020 - Present

Editorial Board, European Journal of Surgical Oncology, 2013 - 2019

Board Member, Annals of Surgical Oncology-Breast Oncology Section, 2011 - 2017

Honors & Awards

2023	Hamill Foundation Distinguished Professorship, UT MD Anderson Cancer Center
2018	American College of Surgeons Traveling Fellow to Japan
2017	Best Poster Award, 12th International Gastric Cancer Congress (IGCC), Beijing China
2014	J. Bradley Aust Award for best paper by a new member, Western Surgical Association
2014	Palliative Medicine Access Fund Scholarship, American Academy of Hospice and Palliative Medicine
2012	Dean’s List, UAMS Circle of Excellence
2011	Dean’s List, UAMS Circle of Excellence
2011 - 2012	Teaching Award, UAMS Red Sash
2011	Arkansas’ Best Doctors, Arkansas Times, Pancreatic Cancer & Melanoma
2010	Scholarship, American College of Surgeons, Outcomes Research Course, Resident and Associate Society Leadership Scholarship Committee
2010	Arkansas’ Best Doctors, Arkansas Times, Oncologic Surgeon
2010	Dean’s List, UAMS Circle of Excellence
2009	Dean's List, UAMS Circle of Excellence
2008	Dean’s List, UAMS Circle of Excellence
2008	Merit Award, Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology
2003	Eighth Annual Resident Research Conference, 1st place, The Ohio State University
2002	2nd Place, Columbus Surgical Society Research Symposium
2002	American Medical Association Research Seed Grant, American Medical Association
2002	John P. Minton Oncology Award, ACS-OH Chapter
2002	Seventh Annual Resident Research Conference, 1st place, The Ohio State University
2001	1st Place, Columbus Surgical Society Research Symposium
2001	Best Poster Presentation, American Society of Breast Surgeons, 2nd Annual Meeting
2001	Sixth Annual Resident Research Conference, 1st place, The Ohio State University

Professional Memberships

American Surgical Association

2021 - Present

International Society for the Study of Pleura and Peritoneum

2021 - Present

Hope for Stomach Cancer Medical Advisory Board

2020 - Present

Society of Surgery of the Alimentary Tract

2018 - 2021

Ariadne Labs, Brigham and Women's Hospital, Harvard School of Public Health

2014

European Journal of Surgical Oncology

2013 - 2018

Western Surgical Association

2013 - Present

The American Board of Surgery

2012 - Present

The American Society of Clinical Oncology

2012 - Present

The Society of American Gastrointestinal Endoscopic Surgeons

2012 - Present

Association of Academic Surgery

2011 - 2019

American College of Surgeons

2011 - 2019

The Society of Surgical Oncology

2010 - Present

Selected Presentations & Talks

Local Presentations

2025. Perioperative Considerations and Complications for Gastric Cancers, AstraZeneca Scientific Workshop on Management of Resectable and Advanced Gastric/GEJ Adenocarcinoma. Invited. Houston, Texas, US.
2025. Robotic approaches for peritoneal carcinomatosis,. Invited. 3rd MD Anderson Robotic Gastrectomy Course. Houston, Texas, US.
2025. Reconstruction techniques after robotic total gastrectomy. Invited. 3rd MD Anderson Robotic Gastrectomy Course. Houston, Texas, US.
2025. Gastric Cancer, Department of Surgery Grand Rounds. Invited. HCA Houston Healthcare, University of Houston. Houston, Texas, US.
2025. Stomach. Invited. Resident Education Hour and SCORE questions. Houston, Texas, US.
2025. 2ndInternational Gastric Cancer Association Webinar Techniques of Robotic Dissection. Panelist. Part 1 : Robotic dissection for No.6. Houston, Texas, US.
2024. Resident Educational Session: Clinical Cases, Exam Review, and Guidelines for Gastric Cancer. Invited. Virtual: HCA Healthcare Resident Didactics. Houston, Texas, US.
2024. Gastric Cancer: Everything a Surgeon Needs to Know, General Surgery. Invited. HCA Healthcare Educational Series. Houston, Texas, US.
2024. Robotic Approach for Peritoneal Carcinomatosis. Conference. Robotic Approach for Peritoneal Carcinomatosis. Houston, TX, US.
2023. Landmark clinical trials in gastric and gastroesophageal cancer. Conference. Landmark clinical trials in gastric and gastroesophageal cancer. Houston, TX, US.
2022. Integrated Multi-Disciplinary Strategies for the Management of Advanced Solid Tumors. Conference. Integrated Multi-Disciplinary Strategies for the Management of Advanced Solid Tumors. Houston, TX, US.
2022. Gastrectomy – Considerations for Western Patients, MD Anderson Robotic D2 Gastrectomy Course. Conference. Gastrectomy – Considerations for Western Patients, MD Anderson Robotic D2 Gastrectomy Course. Houston, TX, US.
2019. Minimally Invasive HIPEC for Gastric Cancer, Global Advances in Minimally Invasive Surgery Video Session. Conference. Minimally Invasive HIPEC for Gastric Cancer, Global Advances in Minimally Invasive Surgery Video Session. Houston, TX, US.
2018. State of the Union - Gastric Cancer. Conference. State of the Union - Gastric Cancer. Houston, TX, US.
2017. Palliative Surgery. Conference. Palliative Surgery. Houston, TX, US.
2015. How to Run Over Surgical Dogma with Palliative Karma. Conference. How to Run Over Surgical Dogma with Palliative Karma. Houston, TX, US.
2015. How to Run Over Surgical Dogma with Palliative Karma. Conference. How to Run Over Surgical Dogma with Palliative Karma. Houston, TX, US.
2013. Acute and Palliative Surgical Oncology. Conference. Acute and Palliative Surgical Oncology. Houston, TX, US.
2013. Palliative Surgery: Lessons Learned and Moving Forward at MD Anderson. Conference. Palliative Surgery: Lessons Learned and Moving Forward at MD Anderson. Houston, TX, US.
2012. Abdominal Lumps and Bumps. Conference. Abdominal Lumps and Bumps. Houston, TX, US.
2007. Surgical Oncology Emergencies. Conference. Surgical Oncology Emergencies. Houston, TX, US.

Regional Presentations

2024. Wiley Gastric Cancer Knowledge Hub, Case Study, Multidisciplinary treatment for localized gastroesophageal junction cancer. Conference. Wiley Gastric Cancer Knowledge Hub, Case Study, Multidisciplinary treatment for localized gastroesophageal junction cancer, US.
2016. Malignant Bowel Obstruction. Conference. Malignant Bowel Obstruction, US.
2016. "Gastric Cancer: Overview & Surgical Management," Surgical Physician Assistant Continuing Education (SPACE). Conference. "Gastric Cancer: Overview & Surgical Management," Surgical Physician Assistant Continuing Education (SPACE), US.
2014. Gastric and Pancreatic Cancer Surgery. Conference. Gastric and Pancreatic Cancer Surgery, US.
2010. Pancreatic Cancer. Conference. Pancreatic Cancer. Searcy, AR, US.

National Presentations

2026. Evolution of Treatment for Gastric Cancer with Peritoneal Metastasis in the West. Invited. Korean Society of Peritoneal Surface Malignancies 2026 virtual presentation. Seoul, KR.
2026. Palliative Gastrointestinal Cancer Case Presentation. Invited. Gastrointestinal & Hepatobiliary Oncology Session. Steamboat Springs, Colorado, US.
2026. Neoadjuvant Symposium: Newcomers – Gastric Cancer. Steamboat Springs. Invited. 22nd Oncology Updates: Advances and Controversies. Steamboat Springs, Colorado, US.
2026. Panelist for Post-MATTERHORN Clinical Investigations, San Francisco, CA 1/7/2026. Invited. PIONEER: Navigating Gastric Cancer and Gastroesophageal Junction Cancer Horizons Investigator Meeting, Astra Zeneca. San Francisco, California, US.
2026. Curio Science, Best Practices for the Multidisciplinary Treatment of Gastric and GEJ Cancers. Invited. San Francisco, California, US.
2025. American Society of Clinical Oncology. Invited. 63rd Annual Meeting of Japan Society of Clinical Oncology. Yokohama, JP.
2025. ESSO Online Course on the Multidisciplinary Management of Patients with Upper GI Malignancies. Invited. European Society of Surgical Oncology. Houston, Texas, US.
2025. A Phase II Study of Perioperative Intraperitoneal Paclitaxel in Patients with Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology. Invited. 2025 ASCO Annual Meeting. Chicago, IL, US.
2025. Current Trials in North and South America. Invited. 16th International Gastric Cancer Congress. Amsterdam,, NL.
2025. Advances in the Multi-Disciplinary Management of Advanced Gastric Cancer. Invited. 21st Oncology Update: Advances and Controversies. , Steamboat Springs, CO, US.
2024. Phase I Trial of Intraperitoneal Paclitaxel in Patients with Gastric Adenocarcinoma and Peritoneal Carcinomatosis or Positive Peritoneal Cytology. Conference. Phase I Trial of Intraperitoneal Paclitaxel in Patients with Gastric Adenocarcinoma and Peritoneal Carcinomatosis or Positive Peritoneal Cytology. Atlanta, GA, US.
2024. Phase I Trial of Short-Course Chemoradiotherapy followed by Chemotherapy as Total Neoadjuvant Therapy for Patients with Potentially Resectable Gastric Cancer. Conference. Phase I Trial of Short-Course Chemoradiotherapy followed by Chemotherapy as Total Neoadjuvant Therapy for Patients with Potentially Resectable Gastric Cancer. Atlanta, GA, US.
2024. Advances in the Management of Locally Advanced Gastric Cancer. Conference. Advances in the Management of Locally Advanced Gastric Cancer. Steamboat Springs, CO, US.
2023. Hyperthermic Intraperitoneal Chemotherapy: basic concept, current evidence, and future potential. Conference. Hyperthermic Intraperitoneal Chemotherapy: basic concept, current evidence, and future potential. Seoul.
2023. Moderator, Managing Locally Advanced Gastric Cancer and Its Complications. Conference. Moderator, Managing Locally Advanced Gastric Cancer and Its Complications. Boston, MA, US.
2023. Surgical Therapy for Gastric and Gastroesophageal Cancers. Conference. MedStar Georgetown Lombardi Comprehensive Cancer Center. Washington, DC, US.
2023. Gastric Carcinomatosis: Gastrointestinal Visiting Professorship Series. Conference. Gastric Carcinomatosis: Gastrointestinal Visiting Professorship Series. expertEd@SSO webinar, US.
2023. Advances in the Multi-Disciplinary Management of Advanced Gastric Cancer. Conference. Advances in the Multi-Disciplinary Management of Advanced Gastric Cancer. Steamboat Springs, CO, US.
2022. Surgical Therapy for Gastric and Gastroesophageal Cancer. Conference. Gastric and Soft Tissue Neoplasms 2022. Washington, DC, US.
2022. Regional Therapies for Diffuse-type Gastric Cancer. Conference. Hereditary Gastric Cancer Symposium,, US.
2022. Is Curing Stage IV Gastric Cancer Possible. Conference. Debbie’s Dream Foundation Educational Webinar, US.
2021. Surgical Strategies for Stage IV Stomach Cancer. Conference. Merck, TAIHO Oncology, Lilly Oncology, Daiichi-Sankyo, US.
2021. Role for Surgery in Metastatic Gastric Cancer and the Importance of Surgical Staging. Conference. Clinical Congress 2021, US.
2021. Recent Advances in Gastroesophageal Cancers. Conference. 8th Annual Gastric and Soft Tissue Neoplasms.
2021. Surgical Therapy for Gastric Cancer. Conference. 8th Annual Gastric and Soft Tissue Neoplasms.
2021. Proffered Paper Session, GI, non-colorectal. The GASTRIPEC-1 Trial. Conference. Proffered Paper Session, GI, non-colorectal. The GASTRIPEC-1 Trial, US.
2021. Proffered Paper Session, GI, non-colorectal. The GASTRIPEC-I Trial. Conference. Proffered Paper Session, GI, non-colorectal. The GASTRIPEC-I Trial. Virtual Meeting, Paris, US.
2021. Laparoscopic HIPEC. Conference. National Cancer Institute of Singapore Surgical Oncology Symposium 2021.
2021. Adjuvant HIPEC for Gastric Cancer. Conference. SurgOnc Today podcast, US.
2021. Gastric Cancer Updates: EG Junction Cancer. Conference. Clinical Case Management Webinar, US.
2021. Anorectal Infections, Surgical Emergencies in Advanced Cancer Patients. Conference. Anorectal Infections, Surgical Emergencies in Advanced Cancer Patients. Webinar, US.
2021. Free Air, Including Perforation, Surgical Emergencies in Advanced Cancer Patients. Conference. Free Air, Including Perforation, Surgical Emergencies in Advanced Cancer Patients. Webinar, US.
2020. Management of Gastric Peritoneal Carcinomatosis. Conference. SurgOnc Today podcast, US.
2020. Surgical Strategies for Stage IV Stomach Cancer: HIPEC. Conference. Stomach Cancer Awareness Network, Inaugural 1st Hope Webcast, US.
2020. Cytoreductive Surgery of Gastric Cancer with Peritoneal Metastases: Hype vs Facts, Best Practice in Treatment of Gastric Cancer. Conference. Cytoreductive Surgery of Gastric Cancer with Peritoneal Metastases: Hype vs Facts, Best Practice in Treatment of Gastric Cancer, US.
2020. Surgical Management of Localized and Advanced Gastric Cancer. Conference. Medstar Health Network. Washington, DC, US.
2020. Enhanced Recovery can be Applied to Complex Cancer Surgery. Conference. Global Enhancement Recovery Symposium 2020. Houston, TX, US.
2020. A Phase II Trial of Cytoreduction, Gastrectomy, and HIPEC for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology. Conference. A Phase II Trial of Cytoreduction, Gastrectomy, and HIPEC for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology. Orlando, FL, US.
2020. Advances in the Mulitimodality treatment of Gastric Cancer. Conference. 18th Oncology Update: Advances and Controversies. Steamboat, CO, US.
2019. Update on HIPEC in Gastric Cancer, Management of Peritoneal Malignancies: Emerging Data in Heated Intraperitoneal Chemotherapy. Conference. Update on HIPEC in Gastric Cancer, Management of Peritoneal Malignancies: Emerging Data in Heated Intraperitoneal Chemotherapy. San Francisco, CA, US.
2019. Surgical Management of Gastric Neuroendocrine Tumors. Conference. 6th Annual Gastric and Soft Tissue Neoplasms 2019. Washington, DC, US.
2019. Gastric Cancer Updates: EG Junction Cancer. Conference. Gastric Cancer Updates: EG Junction Cancer, US.
2019. Expanding the role of HIPEC in gastric cancer. Conference. 17th Oncology Update. Breckenridge, CO, US.
2018. Open and Minimally Invasive Gastrectomy for Cancer. Conference. Society of Surgical Oncology. Houston, TX, US.
2018. Early Postoperative Risk Calculator for Post Hepatectomy Liver Failure Following Major Hepatectomy. Conference. Early Postoperative Risk Calculator for Post Hepatectomy Liver Failure Following Major Hepatectomy, US.
2018. Surgical Cytoreduction and Regional Chemotherapy: Gastric Cancer. Conference. Surgical Cytoreduction and Regional Chemotherapy: Gastric Cancer. Chicago, IL, US.
2018. Expanding the Indications for HIPEC?. Conference. 16th Oncology Update. Steamboat Springs, CO, US.
2017. Open and Minimally Invasive Gastrectomy and Node Dissection. Conference. Open and Minimally Invasive Gastrectomy and Node Dissection. Houston, TX, US.
2017. Palliative Cancer Surgery. Conference. Mayo Clinic. The Big Island of Hawaii, HI, US.
2017. Surgical Consultations in the Neutropenic Patient – Operate or Observe?. Conference. Mayo Clinic. The Big Island of Hawaii, HI, US.
2017. 15th Oncology Update: Advances & Controversies. Conference. Moderator Palliative Care Symposium. Steamboat Springs, CO, US.
2016. Large, Multi-Disciplinary Care Teams & Practices: Optimizing Every Role. Conference. Large, Multi-Disciplinary Care Teams & Practices: Optimizing Every Role. Washington, DC, US.
2016. Palliative Surgery: What is the Optimal Outcome. Conference. Palliative Surgery: What is the Optimal Outcome. Washington, DC, US.
2016. Bariatric/Foregut Session, Discussant, "High PDL1 expression with low T cell infiltration densities predict for poor survival in gastric cancer patients. Conference. American College of Surgeons, US.
2016. Multimodal Approaches for Advanced Gastroesophageal Junction Cancers – Challenging Cases from the United States and Europe versus Asia. Western. Conference. American Society of Clinical Oncolog. San Francisco, CA, US.
2015. Webinar: A Multidisciplinary Approach to Individualized Care - Gastric Cancer. Conference. National Comprehensive Cancer Network (NCCN), US.
2015. Novel Surgical Options. Conference. Debbie’s Dream Foundation 2015, US.
2015. Palliative Surgery Update. Conference. Palliative Surgery Update. Steamboat Springs, CO, US.
2014. How? Credentialing Issues for Health Professionals,” Team Based Care: Integrating Health Care Professionals into Surgical Practice postgraduate course. Conference. How? Credentialing Issues for Health Professionals,” Team Based Care: Integrating Health Care Professionals into Surgical Practice postgraduate course. San Francisco, CA, US.
2014. Palliative Surgery. Conference. Palliative Surgery. Austin, TX, US.
2014. The Palliative Medicine-Surgery Interface: How to Effectively Work With Your Surgery Colleagues on Complex Cases. Conference. Special Interest Group Symposia, US.

International Presentations

2025. How to Assess Quality of Life in Patients with Peritoneal Carcinomatosis. Invited. 2nd Stage IV Gastric Cancer Congress. , Bertinoro, IT.
2025. Peritoneal carcinomatosis with PCI < 7 may be considered as oligometastasis; Between Light and Shadows. Invited. 2° Metastatic WORKSHOP and Congress Stage IV gastric cancer. Bertinoro, IT.
2024. High PCI gastric cancer patients - alternatives in management and palliative care considerations. Invited. 4th Latin American Congress on Peritoneal Surface Malignancies. Frutillar, CL.
2024. CRS + HIPEC in Gastric Cancer - Procedure Demonstration and Pitfalls. Invited. 4th Latin American Congress on Peritoneal Surface Malignancies. Frutillar, CL.
2024. Prophylactic HIPEC in gastric cancer - best indications and considerations. Invited. 4th Latin American Congress on Peritoneal Surface Malignancies. Frutillar, CL.
2024. Panelist: Peritoneal Surface Oncology Group International Consensus Statements: HIPEC and the Management of Peritoneal Surface Malignancy. Conference. Panelist: Peritoneal Surface Oncology Group International Consensus Statements: HIPEC and the Management of Peritoneal Surface Malignancy. Singapore, SG.
2024. Prophylactic and Neoadjuvant Strategies in Gastric Cancer Peritoneal Disease: A Surgeon’s Perspective, Singhealth Peritoneal Surface Oncology Conference. Conference. Prophylactic and Neoadjuvant Strategies in Gastric Cancer Peritoneal Disease: A Surgeon’s Perspective, Singhealth Peritoneal Surface Oncology Conference. Singapore, SG.
2024. Palliative Surgical Considerations in Peritoneal Carcinomatosis, Singhealth Peritoneal Surface Onc``ology Conference. Conference. Palliative Surgical Considerations in Peritoneal Carcinomatosis, Singhealth Peritoneal Surface Onc``ology Conference. Singapore, SG.
2024. Cytoreductive Surgery and HIPEC in Gastric Cancer, Comprehensive Management of Peritoneal Surface Malignancy Workshop and PIPAC Course. Conference. Cytoreductive Surgery and HIPEC in Gastric Cancer, Comprehensive Management of Peritoneal Surface Malignancy Workshop and PIPAC Course. Singapore, SG.
2024. Phase I Trial of Intraperitoneal Paclitaxel in Patients with Gastric Adenocarcinoma and Peritoneal Carcinomatosis or Positive Peritoneal Cytology. Conference. Phase I Trial of Intraperitoneal Paclitaxel in Patients with Gastric Adenocarcinoma and Peritoneal Carcinomatosis or Positive Peritoneal Cytology. San Francisco, US.
2024. Phase I Trial of Short-Course Chemoradiotherapy followed by Chemotherapy as Total Neoadjuvant Therapy for Patients with Potentially Resectable Gastric Cancer. Conference. Phase I Trial of Short-Course Chemoradiotherapy followed by Chemotherapy as Total Neoadjuvant Therapy for Patients with Potentially Resectable Gastric Cancer. San Francisco, US.
2023. Multisociety Recommendations for Management of Peritoneal Surface Malignancy – Gastric Cancer. Conference. Multisociety Recommendations for Management of Peritoneal Surface Malignancy – Gastric Cancer. Venice, IT.
2022. Practice and Trials of Regional Therapy for Gastric Cancer in the U.S. Conference. Third Annual International Society for the Study of Pleura and Peritoneum. Huntington Beach, US.
2022. Novel Discoveries in HIPEC and Intraperitoneal Chemotherapy. Conference. Singapore Gastric Cancer Consortium, 13th Annual Scientific Meeting, SG.
2022. Acute and Palliative Surgical Oncology – A Focus on Malignant Bowel Obstruction. Conference. NCIS Oncology Grand Rounds, SG.
2022. What are the best surgical treatment options for me?. Conference. Debbie’s Dream Foundation & Korean Cancer Association International Gastric Cancer Patient Educational Symposium, US.
2021. Neoadjuvant laparoscopic HIPEC. Conference. European Society of Surgical Oncology (ESSO), US.
2021. Surgical Options for Advanced Gastric Cancer with Peritoneal Metastases. Surgical Management of Peritoneal Surface Malignancies: Current Approaches and Future Directions. Conference. Surgical Options for Advanced Gastric Cancer with Peritoneal Metastases. Surgical Management of Peritoneal Surface Malignancies: Current Approaches and Future Directions.
2021. Hyperthermic Intraperitoneal Chemotherapy, Current Treatment of Gastric Cancer with Peritoneal Metastasis Webinar. Conference. ISSPP Gastric Cancer Webinar 2021, US.
2020. A Phase II Trial of Cytoreduction, Gastrectomy, and HIPEC for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology. Conference. A Phase II Trial of Cytoreduction, Gastrectomy, and HIPEC for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology. Virtual Meeting, US.
2020. Introduction of Laparoscopy for Treatment of Peritoneal Malignancy from Gastric Cancer. Conference. Introduction of Laparoscopy for Treatment of Peritoneal Malignancy from Gastric Cancer. Seoul.
2019. Innovative Perioperative Treatment in Gastric Cancer – A Surgeon’s Perspective How to Improve Outcomes. Conference. Innovative Perioperative Treatment in Gastric Cancer – A Surgeon’s Perspective How to Improve Outcomes. Prague, CZ.
2019. Gastric HIPEC Trial. Conference. 14th International Symposium on Regional Cancer Therapies. Phoenix, US.
2018. Clinical Trials of HIPEC for Gastric Cancer in the United States. Conference. Clinical Trials of HIPEC for Gastric Cancer in the United States. Tokyo, JP.
2018. Clinical Trials for Peritoneal Metastases- Gastric Cancer. Conference. Clinical Trials for Peritoneal Metastases- Gastric Cancer. Jacksonville, US.
2018. Is There a Role for Locoregional Therapies in Stave IV Esophageal and Gastric Cancer? - Surgical Oncologist Perspective. Conference. 2018 Gastrointestinal Cancers Symposium. San Francisco, US.
2017. PRO-HIPEC has a role in gastric cancer. Conference. PRO-HIPEC has a role in gastric cancer. Madrid, ES.
2017. The Pros and Cons of Palliative Surgical Interventions. Conference. The Pros and Cons of Palliative Surgical Interventions. Rio de Janeiro, BR.
2017. ERAS in Gastrectomies: Impact on Short- and Long-term Outcomes. Conference. ERAS in Gastrectomies: Impact on Short- and Long-term Outcomes. Rio de Janeiro, BR.
2017. Neoadjuvant versus Perioperative Treatment for Gastric Adenocarcinoma. Conference. Neoadjuvant versus Perioperative Treatment for Gastric Adenocarcinoma. Rio de Janeiro, BR.
2017. Debate: HIPEC has a role in gastric cancer. Conference. MD Anderson International Meeting in Gastrointestinal Oncology. Madrid, ES.
2016. Session Moderator. Conference. 69th Annual Cancer Symposium. Boston, US.

Formal Peers

2018. Gastric Cancer and HIPEC/Treatment of Peritoneal Disease. Invited. Buffalo, NY, US.
2018. Intraperitoneal Therapy for Advanced Disease. Invited. Houston, TX, US.
2018. Technical Surgical Considerations. Invited. Houston, TX, US.
2015. Surgical Options for Gastric Cancer. Invited. Ft. Lauderdale, FL, US.
2015. Palliative Surgery. Invited, US.
2013. “Palliative Evaluation, in Search of the Best Outcome”, 4th Annual Spotlight on Transforming Palliative Care. Invited. Baltimore, MD, US.
2013. Acute and Palliative Surgical Oncology. Invited. Baltimore, MD, US.
2012. Cystic Neoplasms of the Pancreas. Invited. Little Rock, AR, US.
2012. Controversies in Oncology Series – Debate on Surgery for Colorectal Carcinomatosis. Invited. Little Rock, AR, US.
2012. Gastrointestinal Malignancies - Case Presentations. Invited. Little Rock, AR, US.
2011. Gallbladder Cancer. Invited. Little Rock, AR, US.
2011. The Tumor Board: An Introduction to the Gastrointestinal Cancer Conference. Invited. Little Rock, AR, US.
2011. Reducing the Burden: A July Noon Series to Conquer Cancer – Colorectal Cancer. Visiting, AR, US.
2011. Gastrointestinal Cancer – lessons from the rear echelon. Invited. Little Rock, AR, US.
2011. Screening and Early Diagnosis of Liver Cancer. Invited. Little Rock, AR, US.
2010. “Melanoma”, Oncology Update for the Primary Care Physician. Invited. Little Rock, AR, US.
2010. Oncologic Emergencies – When to call a surgeon. Invited. Little Rock, AR, US.
2010. Palliative Care: Update of ongoing surgical studies at UAMS. Invited. Little Rock, AR, US.
2009. Laparoscopic Surgery for Colorectal Cancer. Invited. Little Rock, AR, US.
2009. Diagnosis, Management, & Treatment of Pancreatic Cancer. Invited. Little Rock, AR, US.
2009. Pancreatic Adenocarcinoma. Invited. Little Rock, AR, US.
2008. Surgical Complications of Chemotherapy. Invited. Little Rock, AR, US.
2008. Pancreatic Cancer. Invited. Little Rock, AR, US.
2007. Surgical Oncology Emergencies. Invited. Albuquerque, NM, US.
2007. Surgical Oncology Emergencies. Invited. Houston, TX, US.

Less

Grant & Contract Support

Date:	2022 - 2026
Title:	Dissecting SOX9-mediated cancer stemness and immunosuppression for novel strategies in advanced gastric adenocarcinoma
Funding Source:	Department of Defense (DOD)
Role:	Collaborator
ID:	CA210457

Date:	2022 - 2027
Title:	Molecular Dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcnioma
Funding Source:	NIH/NCI
Role:	Collaborator

Date:	2021 - 2025
Title:	Translating Novel Discoveries in Gastric Adenocarcinoma Biology into Therapeutic Advances
Funding Source:	Department of Defense (DOD)
Role:	Co-I
ID:	CA200990

Date:	2020 - 2022
Title:	Phase 1 Trial of Intraperitoneal Paclitaxel in Patients with Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
Funding Source:	Institutional Research Grant
Role:	PI

Date:	2019 - 2021
Title:	Gastric Cancer Project Support Grant
Funding Source:	No Stomach for Cancer
Role:	PI

Date:	2018 - 2020
Title:	Discover Novel Biomarkers/Targets for Advanced Gastric Adenocarcinoma Patients by Exploring Tumor-Associated Exosomes from Malignant Ascites
Funding Source:	Department of Defense (DOD)
Role:	Co-PI
ID:	W81XWH810550

Date:	2017 - 2018
Title:	Phase 2 Trial of Gastrectomy, Cytoreduction and Hyperthermic Intraperitoneal Perfusion for Stage IV Gastric Cancer
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	PI

Date:	2015 - 2018
Title:	Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families Project Title: Symptom Burden in Patients with Advanced Cancer and Bowel Obstruction
Funding Source:	American Cancer Society (ACS)
Role:	PI
ID:	127477-PEP-15-054-01-PCSM

Date:	2014 - 2016
Title:	Comprehensive Geriatric Assessment in Patients Undergoing Abdominal Cancer Surgery
Funding Source:	MD Anderson Cancer Center
Role:	PI

Date:	2013 - 2018
Title:	Acute and Palliative Surgical Oncology
Funding Source:	MD Anderson Cancer Center
Role:	Program Leader

Date:	2012 - 2014
Title:	A Phase III Study of Chemotherapy and Chemoradiotherapy with or without HyperAcute-Pancreas Immunotherapy in Subjects with Pancreatic Cancer
Funding Source:	Newlink Genetics
Role:	Co-I

Date:	2012 - 2013
Title:	Evaluating symptom control and quality of life in surgical palliation
Funding Source:	University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute Auxilliary Award
Role:	PI

Date:	2012 - 2013
Title:	Evaluating symptom control and quality of life in surgical palliation
Funding Source:	University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute Auxilliary Award
Role:	PI

Date:	2011 - 2013
Title:	A Phase II Randomized Study of Solifenacin Compared to Clonidine for Reducing Hot Flashes among Breast Cancer Patients
Funding Source:	Arkansas Breast Cancer Research Program
Role:	Co-I

Date:	2011 - 2012
Title:	Geriatric assessment in cancer patients undergoing elective abdominal surgery
Funding Source:	University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute Auxilliary Award
Role:	PI

Date:	2010 - 2011
Title:	The relationship between ABO blood type/ethnicity and colorectal cancer outcomes
Funding Source:	University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute Auxilliary Award
Role:	Co-I
ID:	NSABP G1-37949-01

Date:	2010 - 2011
Title:	Adjunctive radiofrequency ablation following lumpectomy for breast cancer
Funding Source:	ABLATE Registry, Angiodynamics, Inc
Role:	Co-I

Date:	2010 - 2011
Title:	Pilot project of saliva-based genomic markers for pancreatic cancer
Funding Source:	University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute Auxilliary Award
Role:	PI

Date:	2010 - 2012
Title:	Geriatric assessment in cancer patients undergoing elective abdominal surgery
Funding Source:	University of Arkansas for Medical Sciences Medical Research Endowment Award
Role:	PI

Date:	2010 - 2010
Title:	Evaluating symptom control and quality of life in patients with advanced or incurable malignancies requiring surgical evaluation
Funding Source:	University of Arkansas for Medical Sciences MRE Endowment Award
Role:	PI

Date:	2001 - 2002
Title:	The Anti-Tumor Effects of Interferon-Alpha Are Maintained in Mice Challenged with a STAT1-Deficient Murine Melanoma Cell Line
Funding Source:	American Medical Association
Role:	PI

Date:	2001 - 2002
Title:	Molecular mechanisms of IFN-α in JAK-STAT signaling in malignant melanoma
Funding Source:	The Ohio State University Department of General Surgery
Role:	PI

Title:	Palliative surgical oncology, Arkansas Cancer Plan
Funding Source:	Arkansas Cancer Coalition Mini-Grant
Role:	Co-I

Selected Publications

Peer-Reviewed Articles

Ikoma N, Grotz T, Kawakubo H, Kim HI, Matsuda S, Okui J, Tomita K, Hirata Y, Nakao A, Williams LA, Wang XS, Wang X, Mansfield PF, Hyung WJ, Badgwell BD, Strong VE, Kitagawa Y. Transpacific multicenter collaborative study of minimally invasive proximal gastrectomy vs. minimally invasive total gastrectomy for proximal gastric and gastroesophageal junction cancers: 3-month follow-up results. Surg Endosc, 2025. e-Pub 2025. PMID: 41023216.
Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL, Olecki E, Radomski SN, Sun B, Turaga KK, Gunderson CG, Lacy J, Badgwell BD, In H, Kennedy T, Yoon HH, Greer JB, Sundar R, Woo Y. Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases. Cancer 131(13):e35870, 2025. e-Pub 2025. PMID: 40558029.
Sewastjanow-Silva M, Xiao L, Abdelhakeem A, Pabon CM, Yamashita K, Yoshimura K, Badgwell BD, Ikoma N, Meyer L, Sagebiel T, Das P, Li JJ, Ajani JA, Blum-Murphy MA. Survival Benefit of Palliative Oophorectomy for Patients With Ovarian Metastasis From Baseline Metastatic Gastric Adenocarcinoma. J Clin Oncol:JCO2401678, 2025. e-Pub 2025. PMID: 40446172.
Song Y, Hirata Y, Ajani JA, Blum Murphy M, Li JJ, Das P, Minsky BD, Mansfield PF, Ikoma N, Badgwell BD. ASO Visual Abstract: Survival Outcomes for Patients Who Have Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy. Ann Surg Oncol 31(13):9063-9064, 2024. e-Pub 2024. PMID: 39402317.
Bhutiani N, Seo YD, Robinson KA, White MG, Ikoma N, Mansfield PF, Li JJ, Murphy MB, Ajani JA, Badgwell BD. HIPEC for metastatic gastric cancer: Moving the needle towards 3-year survival. Eur J Surg Oncol 51(1):108790, 2024. e-Pub 2024. PMID: 39489042.
Song Y, Hirata Y, Ajani JA, Blum Murphy M, Li JJ, Das P, Minsky BD, Mansfield PF, Ikoma N, Badgwell BD. Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy. Ann Surg Oncol 31(10):6918-6930, 2024. e-Pub 2024. PMID: 39048909.
Song Y, Chen E, Chiang YJ, Yao JC, Halperin DM, Chatterjee D, Badgwell BD. Classification of Gastric Neuroendocrine Tumors and Associations With Survival. J Surg Oncol, 2024. e-Pub 2024. PMID: 39257200.
Badgwell BD, Ikoma N, Blum M, Wang X, Estrella J, Liu X, Kawedia J, Li J, Mansfield P, Ajani J. Phase 1 trial of intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology. Cancer:Online ahead of prin. e-Pub 2024. PMID: 39287936.
Badgwell BD, Ikoma N, Murphy MB, Li J, Wang X, Minsky BD, Estrella J, Mansfield P, Ajani J, Das P. Phase 1 Trial of Total Neoadjuvant Therapy With Short-Course Chemoradiotherapy Followed by Chemotherapy for Patients With Potentially Resectable Gastric Cancer. Int J Radiat Oncol Biol Phys. e-Pub 2024. PMID: 39237045.
Cass SH, Williams LA, Rajaram R, Hirata Y, Rice D, Tzeng CD, Katz MHG, Badgwell BD, Wang XS, Ikoma N. Patient-reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study. J Surg Oncol. e-Pub 2024. PMID: 38798277.
Song Y, Chen E, Ikoma N, Mansfield PF, Bruera E, Badgwell BD. ASO Visual Abstract: Palliative Surgery for Patients with Gastroesophageal Junction or Gastric Cancer-A Report on Clinical Observational Outcomes. Ann Surg Oncol. e-Pub 2024. PMID: 38797787.
Song Y, Chen E, Ikoma N, Mansfield PF, Bruera E, Badgwell BD. Palliative Surgery for Patients with Gastroesophageal Junction or Gastric Cancer: A Report on Clinical Observational Outcomes. Ann Surg Oncol. e-Pub 2024. PMID: 38743284.
Hirata Y, To C, Lyu H, Smith GL, Samuel JP, Cao HST, Badgwell BD, Katz MHG, Ikoma N. ASO Visual Abstract: Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy. Ann Surg Oncol. e-Pub 2024. PMID: 38735902.
Hirata Y, To C, Lyu H, Smith GL, Samuel JP, Tran Cao HS, Badgwell BD, Katz MHG, Ikoma N. Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy. Ann Surg Oncol. e-Pub 2024. PMID: 38536586.
Hirata Y, Lyu HG, Azimuddin AM, Lu P, Ajith J, Schmeisser JA, Ninan EP, Lee KH, Badgwell BD, Mansfield P, Ikoma N. Cost Analysis for Robotic and Open Gastrectomy. Ann Surg Open 5(1):e396, 2024. e-Pub 2024. PMID: 38883961.
Badgwell B, Estrella J, Roy-Chowdhuri S, Ikoma N, Blum Murphy M, Ajani J, Mansfield P. Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer. Ann Surg Oncol. e-Pub 2024. PMID: 38286882.
Hirata Y, Gottumukkala V, Ajith J, Schmeisser JA, Ninan EP, Maxwell JE, Snyder RA, Kim MP, Tran Cao HS, Tzeng CD, Badgwell BD, Katz MHG, Ikoma N. Laparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis. Langenbecks Arch Surg 409(1):16, 2023. e-Pub 2023. PMID: 38147123.
Hirata Y, Chiang YJ, Estrella JS, Das P, Minsky BD, Blum Murphy M, Ajani JA, Mansfield P, Badgwell BD, Ikoma N. Independent Stage Classification for Gastroesophageal Junction Adenocarcinoma. Cancers (Basel) 15(21), 2023. e-Pub 2023. PMID: 37958312.
Daniel SK, Badgwell BD, McKinley SK, Strong VE, Poultsides GA. Great Debate: Chemoradiation Should be Added to Chemotherapy as a Neoadjuvant Treatment Strategy for Resectable Gastric Adenocarcinoma. Ann Surg Oncol. e-Pub 2023. PMID: 37865940.
Lilley EJ, Lu P, Robinson K, Griffith H, Mansfield P, Ikoma N, Badgwell BD. High symptom burden in patients undergoing gastrectomy for cancer. J Surg Oncol. e-Pub 2023. PMID: 37849370.
Hirata Y, Chiang YJ, Mansfield P, Badgwell BD, Ikoma N. Trends of Oncological Quality of Robotic Gastrectomy for Gastric Cancer in the United States. World J Oncol 14(5):371-381, 2023. e-Pub 2023. PMID: 37869235.
Ikoma N, Grotz T, Kawakubo H, Kim HI, Matsuda S, Hirata Y, Nakao A, Williams LA, Wang XS, Mendoza T, Wang X, Badgwell BD, Mansfield PF, Hyung WJ, Strong VE, Kitagawa Y. Trans-pacific multicenter collaborative study of minimally invasive proximal versus total gastrectomy for proximal gastric and gastroesophageal junction cancers. BMC Surg 23(1):262, 2023. e-Pub 2023. PMID: 37653380.
Krouse RS, Anderson GL, Arnold KB, Thomson CA, Nfonsam VN, Al-Kasspooles MF, Walker JL, Sun V, Alvarez Secord A, Han ES, Leon-Takahashi AM, Isla-Ortiz D, Rodgers P, Hendren S, Sanchez Salcedo M, Laryea JA, Graybill WS, Flaherty DC, Mogal H, Miner TJ, Pimiento JM, Kitano M, Badgwell B, Whalen G, Lamont JP, Guevara OA, Senthil MS, Dewdney SB, Silberfein E, Wright JD, Friday B, Fahy B, Anantha Sathyanarayana S, O'Rourke M, Bakitas M, Sloan J, Grant M, Deutsch GB, Deneve JL. Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial. Lancet Gastroenterol Hepatol. e-Pub 2023. PMID: 37541263.
Hirata Y, Agnes A, Estrella JS, Blum Murphy M, Das P, Minsky BD, Ajani JA, Badgwell BD, Mansfield P, Ikoma N. Clinical Impact of Positive Surgical Margins in Gastric Adenocarcinoma in the Era of Preoperative Therapy. Ann Surg Oncol 30(8):4936-4945, 2023. e-Pub 2023. PMID: 37106276.
Hirata Y, Agnes A, Estrella JS, Blum M, Das P, Minsky BD, Ajani JA, Badgwell BD, Mansfield P, Ikoma N. ASO Visual Abstract: Clinical Impact of Positive Surgical Margins in Gastric Adenocarcinoma in the Era of Preoperative Therapy. Ann Surg Oncol 30(8):4948-4949, 2023. e-Pub 2023. PMID: 37193894.
Zhao S, Wang R, Song S, Hao D, Han G, Song X, Zhang J, Pizzi MP, Shanbhag N, Futreal A, Badgwell B, Harada K, Calin G, Vykoukal J, Yu CY, Katayama H, Hanash SM, Wang L, Ajani JA. Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases. iScience 26(6):106913, 2023. e-Pub 2023. PMID: 37305699.
Hirata Y, Mansfield P, Badgwell BD, Ikoma N. Evidence-Based Surgical Approach to Gastroesophageal Junction Cancer: How We Do Robotic Transhiatal Lower Mediastinal Dissection and Esophagojejunostomy. Ann Surg Oncol 30(5):2956, 2023. e-Pub 2023. PMID: 36658247.
Mitchell KG, Bayley EM, Ikoma N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Erasmus JJ, Weston BR, Ajani JA, Badgwell BD, Hofstetter WL. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma. Ann Thorac Surg. e-Pub 2023. PMID: 37080372.
Hirata Y, Agnes A, Arvide EM, Robinson KA, To C, Griffith HL, LaRose MD, Munder KM, Mansfield P, Badgwell BD, Ikoma N. Short-Term and Textbook Surgical Outcomes During the Implementation of a Robotic Gastrectomy Program. J Gastrointest Surg. e-Pub 2023. PMID: 36917404.
Ayabe RI, Mendoza T, Yennu S, Bruera E, Williams LA, Badgwell B. Symptom Burden in Patients with Malignant Bowel Obstruction Treated With or Without Surgery. J Am Coll Surg 236(3):514-522, 2023. e-Pub 2023. PMID: 36729796.
Green BL, Blumenthaler AN, Gamble LA, McDonald JD, Robinson K, Connolly M, Epstein M, Hernandez JM, Blakely AM, Badgwell BD, Davis JL. ASO Visual Abstract: Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials. Ann Surg Oncol 30(3):1861-1862, 2023. e-Pub 2023. PMID: 36434483.
Green BL, Blumenthaler AN, Gamble LA, McDonald JD, Robinson K, Connolly M, Epstein M, Hernandez JM, Blakely AM, Badgwell BD, Davis JL. Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials. Ann Surg Oncol 30(3):1852-1860, 2023. e-Pub 2023. PMID: 36348206.
Blumenthaler AN, Robinson KA, Hodge C, Xiao L, Lilley EJ, Griffin JF, White MG, Day R, Tanco K, Bruera E, Badgwell BD. Communication Frameworks for Palliative Surgical Consultations: A Randomized Study of Advanced Cancer Patients. Ann Surg. e-Pub 2023. PMID: 36806227.
Blumenthaler AN, Bruera E, Badgwell BD. Palliative and Supportive Care Consultation for Patients With Malignant Gastrointestinal Obstruction is Associated With Broad Interdisciplinary Management. Ann Surg 277(2):284-290, 2023. e-Pub 2023. PMID: 36745760.
Vassilakopoulou M, Chen HC, Wang X, Harada K, Iwatsuki M, Das P, Blum Murphy M, Matamoros A, Sagebiel T, Devine C, Thomas I, Sanders EM, Shanbhag N, Rogers JE, Lee JH, Weston B, Bhutani MS, Hofstetter W, Nguyen QN, Badgwell BD, Ajani JA. Localized Gastroesophageal Adenocarcinoma in the Elderly: Is Age a Factor Associated with Suboptimal Treatment?. Oncology 101(3):153-158, 2023. e-Pub 2023. PMID: 36412619.
Badgwell B, Williams LA, Chen TH, Cleeland C, Mendoza T. Development and Validation of a Patient-reported Outcome Measure for Gastrointestinal Obstruction in the Setting of Advanced Malignancy. Ann Surg 276(6):e805-e811, 2022. e-Pub 2022. PMID: 33630455.
Hirata Y, Kim HI, Grotz TE, Matsuda S, Badgwell BD, Ikoma N. The role of proximal gastrectomy in gastric cancer. Chin Clin Oncol 11(5):39, 2022. e-Pub 2022. PMID: 36336898.
Hirata Y, Agnes A, Prakash LR, Mansfield P, Badgwell BD, Ikoma N. Borrmann Type Predicts Response to Preoperative Therapy in Advanced Gastric Cancer. J Gastrointest Cancer. e-Pub 2022. PMID: 36308675.
Hirata Y, Witt RG, Prakash LR, Arvide EM, Robinson KA, Gottumukkala V, Tzeng CD, Mansfield P, Badgwell BD, Ikoma N. ASO Visual Abstract: Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy. Ann Surg Oncol 29(9):5873-5874, 2022. e-Pub 2022. PMID: 35771369.
Hirata Y, Witt RG, Prakash LR, Arvide EM, Robinson KA, Gottumukkala V, Tzeng CD, Mansfield P, Badgwell BD, Ikoma N. Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy. Ann Surg Oncol 29(9):5861-5870, 2022. e-Pub 2022. PMID: 35507230.
Weng J, Ajani JA, Murphy MB, Badgwell BD, Tchakarov AS, Mamlouk O, Das P. Immunotherapy Recall: Chemoradiation-Induced Reactivation of Immune Checkpoint Inhibitor Nephritis. JCO Precis Oncol 6:e2200049, 2022. e-Pub 2022. PMID: 35952321.
DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, Consortium P. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
Hirata Y, Scally C, Badgwell BD, Ikoma N. Robotic excision of gastric and duodenal gastrointestinal stromal tumor. Updates Surg. e-Pub 2022. PMID: 35247206.
Erstad DJ, Blum M, Estrella JS, Das P, Minsky BD, Ajani JA, Mansfield PF, Badgwell BD, Ikoma N. Determinants of Survival for Patients with Neoadjuvant-Treated Node-Negative Gastric Cancer. Ann Surg Oncol 28(11):6638-6648, 2021. e-Pub 2021. PMID: 33754224.
Erstad DJ, Blum M, Estrella JS, Das P, Minsky BD, Ajani JA, Mansfield PF, Ikoma N, Badgwell BD. Benchmarks for nodal yield and ratio for node-positive gastric cancer. Surgery 170(4):1231-1239, 2021. e-Pub 2021. PMID: 34059344.
Erstad DJ, Blum M, Estrella JS, Das P, Minsky BD, Ajani JA, Mansfield PF, Ikoma N, Badgwell BD. Navigating Nodal Metrics for Node-Positive Gastric Cancer in the United States: An NCDB-Based Study and Validation of AJCC Guidelines. J Natl Compr Canc Netw:1-12. e-Pub 2021. PMID: 34678759.
Allen CJ, Pointer DT, Blumenthaler AN, Mehta RJ, Hoffe SE, Minsky BD, Smith GL, Blum M, Mansfield PF, Ikoma N, Das P, Ajani J, Dineen SP, Fleming JB, Badgwell BD, Pimiento JM. Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis. Ann Surg 274(4):544-548, 2021. e-Pub 2021. PMID: 34132693.
Ikoma N, Kim MP, Tran Cao HS, Prakash LP, Maxwell JE, Tzeng CD, Mansfield PF, Lee JE, Badgwell BD, Katz MHG. Early Experience of a Robotic Foregut Surgery Program at a Cancer Center: Video of Shared Steps in Robotic Pancreatoduodenectomy and Gastrectomy. Ann Surg Oncol. e-Pub 2021. PMID: 34515886.
Abdelhakeem A, Patnana M, Wang X, Rogers JE, Murphy MB, Sagebiel T, Ikoma N, Badgwell BD, Trail A, Estrella JS, Lu Y, Devine C, Ajani JA. Influence of Baseline Positron Emission Tomography in Metastatic Gastroesophageal Cancer on Survival and Response to Therapy. Oncology. e-Pub 2021. PMID: 34352788.
Blumenthaler AN, Robinson KA, Kruse BC, Munder K, Ikoma N, Mansfield PF, Gottumukkala V, Kapoor R, Badgwell BD. Implementation of a perioperative-enhanced recovery protocol in patients undergoing open gastrectomy for gastric cancer. J Surg Oncol. e-Pub 2021. PMID: 34227691.
Ikoma N, Estrella JS, Blum Murphy M, Das P, Minsky BD, Mansfield P, Ajani JA, Badgwell BD. Tumor Regression Grade in Gastric Cancer After Preoperative Therapy. J Gastrointest Surg 25(6):1380-1380, 2021. e-Pub 2021. PMID: 32542556.
Song S, Xu Y, Huo L, Zhao S, Wang R, Li Y, Scott AW, Pizzi MP, Wang Y, Fan Y, Harada K, Jin J, Ma L, Yao X, Shanbhag ND, Gan Q, Roy-Chowdhuri S, Badgwell BD, Wang Z, Wang L, Ajani JA. Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma. J Exp Clin Cancer Res 40(1):207, 2021. e-Pub 2021. PMID: 34162421.
Ikoma N, Badgwell BD, Mansfield PF. Robotic Proximal Gastrectomy with Double-Tract Reconstruction for Gastroesophageal Junction Cancer. J Gastrointest Surg. e-Pub 2021. PMID: 33655471.
Blumenthaler AN, Newhook TE, Ikoma N, Estrella JS, Blum Murphy M, Das P, Minsky BD, Ajani JA, Mansfield PF, Badgwell BD. Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival. J Surg Oncol 123(4):911-922, 2021. e-Pub 2021. PMID: 33400838.
Ikoma N, Mansfield PF, Badgwell BD. Robotic D2 Total Gastrectomy with Fluorescent Lymphatic Mapping for Gastric Cancer: Effective Use of the 4th Arm. J Gastrointest Surg. e-Pub 2021. PMID: 33728592.
Allen CJ, Blumenthaler AN, Smith GL, Das P, Minsky BD, Blum M, Ajani J, Mansfield PF, Ikoma N, Badgwell BD. Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience. Ann Surg Oncol 28(2):758-765, 2021. e-Pub 2021. PMID: 32696305.
Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, Zhao M, Tatlonghari G, Zhang S, Hao D, Lu Y, Zhao S, BD B, Blum Murphy M, Shanbhag N, Estrella JS, Roy-Chowdhuri S, Abdelhakeem AAF, Wang Y, Peng G, Hanash S, Calin GA, Song X, Chu Y, Zhang J, Li M, Chen K, Lazar AJ, Futreal A, Song S, Ajani JA, Wang L. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat Med 27(1):141-151, 2021. e-Pub 2021. PMID: 33398161.
Abdelhakeem AA, Wang X, Waters RE, Patnana M, Estrella JS, Blum Murphy M, Trail AM, Lu Y, Devine CE, Ikoma N, Das P, Badgwell BD, Rogers JE, Ajani JA. Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy Response. Cancers (Basel) 13(3), 2021. e-Pub 2021. PMID: 33498613.
Blumenthaler AN, Allen CJ, Ikoma N, Blum M, Das P, Minsky BD, Mansfield PF, Ajani JA, Badgwell BD. Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma. Ann Surg Oncol 27(13):5047-5056, 2020. e-Pub 2020. PMID: 32737700.
Blumenthaler AN, Ikoma N, Blum M, Das P, Minsky BD, Mansfield PF, Ajani JA, Badgwell BD. Relationship between initial management strategy and survival in patients with gastric outlet obstruction due to gastric cancer. J Surg Onc 122(7):1373-1382, 2020. e-Pub 2020. PMID: 32810292.
Davis CH, Ikoma N, Mansfield PF, Das P, Minsky BD, Blum MA, Ajani JA, Bass BL, Badgwell BD. Comparison of laparoscopy versus mini-laparotomy for jejunostomy placement in patients with gastric adenocarcinoma. Surg Endosc. e-Pub 2020. PMID: 33170336.
Harada K, Patnana M, Wang X, Iwatsuki M, Murphy MAB, Zhao M, Das P, Minsky BD, Weston B, Lee JH, Bhutani MS, Estrella JS, Shanbhag N, Ikoma N, Badgwell BD, Ajani JA. Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells. Surg Today 50(10):1223-1231, 2020. e-Pub 2020. PMID: 32409870.
Kim BJ, Chiang YJ, Das P, Minsky BD, Blum MA, Ajani JA, Estrella JS, Hofstetter WL, Tzeng CD, Badgwell BD, Mansfield PF, Ikoma N. Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States. J Clin Med 9(11):E3495, 2020. e-Pub 2020. PMID: 33138060.
Stark AP, Blum MM, Chiang YJ, Das P, Minsky BD, Estrella JS, Ajani JA, Badgwell BD, Mansfield P, Ikoma N. Preoperative Therapy Regimen Influences the Incidence and Implication of Nodal Downstaging in Patients with Gastric Cancer. J Gastric Cancer 20(3):313-327, 2020. e-Pub 2020. PMID: 33024587.
Stark AP, Estrella JS, Chiang YJ, Das P, Minsky BD, Blum Murphy MA, Ajani JA, Mansfield P, Badgwell BD, Ikoma N. Impact of tumor regression grade on recurrence after preoperative chemoradiation and gastrectomy for gastric cancer. J Surg Oncol 122(3):422-432, 2020. e-Pub 2020. PMID: 32462681.
Williams LA, Bruera E, Badgwell B. In Search of the Optimal Outcome Measure for Patients with Advanced Cancer and Gastrointestinal Obstruction: A Qualitative Research Study. Ann Surg Onc 27(8):2646-2652, 2020. e-Pub 2020. PMID: 32152776.
Zafar SN, Blum M, Chiang YJ, Ajani JA, Estrella JS, Das P, Minsky BD, Hofstetter WL, Mansfield P, Badgwell BD, Ikoma N. Preoperative Chemoradiation versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma. Ann Thorac Surg 110(2):398-405, 2020. e-Pub 2020. PMID: 32289300.
White MG, Kothari A, Ikoma N, Murphy MB, Song S, Ajani J, Mansfield P, Badgwell B. Factors Associated with Resection and Survival After Laparoscopic HIPEC for Peritoneal Gastric Cancer Metastasis. Ann Surg Oncol. e-Pub 2020. PMID: 32648181.
Blumenthaler AN, Allen CJ, Ikoma N, Blum M, Das P, Minsky BD, Mansfield PF, Ajani JA, Badgwell BD. Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma. Ann Surg Oncol. e-Pub 2020.
Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer 1;26(11), 2020. e-Pub 2020. PMID: 32282077.
Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. Cancer 1:26(11):2566-2570, 2020. e-Pub 2020. PMID: 32282072.
Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. Cancer 1;26(11):2525-2533, 2020. e-Pub 2020. PMID: 32282073.
Badgwell B, Ikoma N, Murphy MB, Wang X, Estrella J, Roy-Chowdhuri S, Das P, Minsky BD, Lano E, Song S, Mansfield P, Ajani J. A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology. Ann Surg Oncol. e-Pub 2020. PMID: 32556731.
Mizrak Kaya D, Nogueras González GM, Harada K, Blum Murphy MA, Lee JH, Bhutani MS, Weston B, Thomas I, Rogers JE, Das P, Badgwell BD, Ajani JA. Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma. Oncology 98(8):542-548. e-Pub 2020. PMID: 32434189.
Santos D, Ledet CR, Limmer A, Gibson H, Badgwell B. Use of non-operative treatment and interval cholecystectomy for cholecystitis in patients with cancer. Trauma Surg Acute Care Open 5(1):e000439, 2020. e-Pub 2020. PMID: 32420452.
Ikoma N, Badgwell BD, Mansfield P. Fluorescent-Image Guidance in Robotic Subtotal Gastrectomy. Am J Surg. e-Pub 2020. PMID: 32382891.
Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Murphy MAB, Maru DM, Weston B, Lee JH, Rogers JE, Trail A, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Das P, Hofstetter WL, Badgwell BD, Ajani JA. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases. Gastric Cancer. e-Pub 2020. PMID: 32347396.
Scally CP, Robinson K, Blumenthaler AN, Bruera E, Badgwell BD. Identifying Core Principles of Palliative Care Consultation in Surgical Patients and Potential Knowledge Gaps for Surgeons. J Am Coll Surg. e-Pub 2020. PMID: 32311465.
Ajani JA, Xu Y, Huo L, Wang R, Li Y, Wang Y, Pizzi MP, Scott A, Harada K, Ma L, Yao X, Jin J, Zhao W, Dong X, Badgwell BD, Shanbhag N, Tatlonghari G, Estrella JS, Roy-Chowdhuri S, Kobayashi M, Vykoukal JV, Hanash SM, Calin GA, Peng G, Lee JS, Johnson RL, Wang Z, Wang L, Song S. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition. Gut. e-Pub 2020. PMID: 32345613.
Allen CJ, Vreeland TJ, Newhook TE, Das P, Minsky BD, Blum M, Ajani J, Ikoma N, Mansfield PF, Badgwell BD. Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer. Ann Surg Oncol 27(2):534-542, 2020. e-Pub 2020. PMID: 31552618.
Allen CJ, Blumenthaler AN, Das P, Minsky BD, Blum M, Roy-Chowdhuri S, Ajani JA, Ikoma N, Mansfield PF, Badgwell BD. Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma. World J Surg Oncol 18(1):39, 2020. e-Pub 2020. PMID: 32066454.
Blum Murphy M, Ikoma N, Wang X, Estrella J, Roy-Chowdhuri S, Das P, Minsky BD, Song S, Mansfield P, Ajani J, Badgwell B. Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology. Ann Surg Onc. e-Pub 2020. PMID: 31974712.
Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases. Cancer 1:26(11), 2020. e-Pub 2020. PMID: 32282074.
Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, Xu Y, Zhao W, Dong X, Jin J, Wang Y, Scott A, Ma L, Huo L, Vicente D, Blum Murphy M, Shanbhag N, Tatlonghari G, Thomas I, Rogers J, Kobayashi M, Vykoukal J, Estrella JS, Roy-Chowdhuri S, Han G, Zhang S, Mao X, Song X, Zhang J, Gu J, Johnson RL, Calin GA, Peng G, Lee JS, Hanash SM, Futreal A, Wang Z, Wang L, Ajani JA. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut 69(1):18-31, 2020. e-Pub 2020. PMID: 31171626.
Allen CJ, Newhook TE, Vreeland TJ, Das P, Minsky BD, Blum M, Song S, Ajani J, Ikoma N, Mansfield PF, Roy-Chowdhuri S, Badgwell BD. Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer. J Surg Onc 120(8):1350-1357, 2019. e-Pub 2019. PMID: 31612494.
Sonoda K, Samdani RT, Ikoma N, Kaya DM, Blum-Murphy M, Ajani JA, Badgwell BD, Katz MH, Rashid A, Estrella JS. Gastric cancer in the remnant stomach after pancreaticoduodenectomy: A case series. J Surg Onc 120(7):1137, 2019. e-Pub 2019. PMID: 31498442.
Moningi S, Ajani JA, Badgwell BD, Murphy MB, Ikoma N, Mansfield PF, Ho JC, Suh Y, Crane C, Herman JM, Holliday EB, Koay E, Koong AC, Krishnan S, Minsky B, Smith G, Taniguchi C, Das P. IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer. Adv Radiat Oncol 28(5(3)):369-376, 2019. e-Pub 2019. PMID: 32529130.
Ikoma N, Estrella JS, Hofstetter WL, Ajani JA, Fournier KF, Mansfield PF, Skibber JM, Badgwell BD. Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique. J Gastrointest Surg 22(11):2013-2019, 2019. e-Pub 2019. PMID: 30054780.
Ikoma N, Agnes A, Chen HC, Wang X, Blum MM, Das P, Minsky B, Estrella JS, Mansfield P, Ajani JA, Badgwell BD. Linitis Plastica: a Distinct Type of Gastric Cancer. J Gastrointest Surg. e-Pub 2019. PMID: 31754987.
Stark AP, Ikoma N, Chiang YJ, Estrella JS, Das P, Minsky BD, Blum MM, Ajani JA, Mansfield P, Badgwell BD. Characteristics and Survival of Gastric Cancer Patients with Pathologic Complete Response to Preoperative Therapy. Ann Surg Oncol 26(11):3602-3610, 2019. e-Pub 2019. PMID: 31350645.
Newhook TE, Badgwell BD. Reply to the Letter to the Editor Regarding "Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy". Ann Surg Onc 26(9):3011-3012, 2019. e-Pub 2019. PMID: 31286310.
Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation For Siewert II/III Adenocarcinoma. Ann Thorac Surg 108(3):845-851, 2019. e-Pub 2019. PMID: 31102632.
Ikoma N, Kim B, Elting LS, Shih YT, Badgwell BD, Mansfield P. Trends in Volume-Outcome Relationship in Gastrectomies in Texas. Ann Surg Onc. e-Pub 2019. PMID: 31264116.
Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JA. Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Ann Surg. e-Pub 2019. PMID: 31188215.
Newhook TE, Agnes A, Blum M, Estrella JS, Das P, Ho L, Ajani JA, Minsky BD, Mansfield P, Badgwell BD. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy. Ann Surg Oncol 26(5):1394-1400, 2019. e-Pub 2019. PMID: 30680477.
Kapoor R, Robinson KA, Cata JP, Owusu-Agyemang P, Soliz JM, Hernandez M, Mansfield P, Badgwell B. Assessment of nephrotoxicity associated with combined cisplatin and mitomycin C usage in laparoscopic hyperthermic intraperitoneal chemotherapy. Intl J Hyperthermia 36(1):493-498, 2019. e-Pub 2019. PMID: 30935256.
Ikoma N, Das P, Hofstetter W, Ajani JA, Estrella JS, Chen HC, Wang X, Callender RA, Zhu C, Roland CL, Fournier KF, Cormier JN, Mansfield P, Badgwell BD. Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching. Gastric Cancer 21(6):1004-1013, 2018. e-Pub 2018. PMID: 29730720.
Vicente D, Ikoma N, Chiang YJ, Fournier K, Tzeng CD, Song S, Mansfield P, Ajani J, Badgwell BD. Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy. Ann Surg Oncol 25(9):2720-2730, 2018. e-Pub 2018. PMID: 29987602.
Ikoma N, Estrella JS, Blum M, Das P, Chen HC, Wang X, Fournier K, Mansfield P, Ajani J, Badgwell BD. Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative Therapy. J Gastrointest Surg 22(8):1325-1333, 2018. e-Pub 2018. PMID: 29679346.
Ikoma N, Estrella JS, Hofstetter WL, Ajani JA, Fournier KF, Mansfield PF, Skibber JM, Badgwell BD. Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique. Journal of Gastrointestinal Surgery. e-Pub 2018. PMID: 30054780.
Mizrak Kaya D, Nogueras-Gonzáles GM, Harada K, Amlashi FG, Thomas I, Rogers JE, Bhutani MS, Lee JH, Weston B, Minsky BD, Estrella JS, Blum Murphy MA, Jr MA, Devine CE, Das P, Badgwell BD, Ajani JA. Potentially curable gastric adenocarcinoma treated without surgery. Eur J Cancer(98):23-29, 2018. e-Pub 2018. PMID: 29859338.
Ikoma N, Hofstetter WL, Estrella JS, Das P, Minsky BD, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD. The ypT category does not impact overall survival in node negative gastric cancer. J Surg Oncol 117(8):1721-1728, 2018. e-Pub 2018. PMID: 29949666.
Thiels CA, Ikoma N, Fournier K, Das P, Blum M, Estrella JS, Minsky BD, Ajani J, Mansfield P, Badgwell BD. Repeat staging laparoscopy for gastric cancer after preoperative therapy. J Surg Oncol 118(1):61-67, 2018. e-Pub 2018. PMID: 29878364.
Ikoma N, Estrella JS, Hofstetter W, Das P, Minsky BD, Ajani JA, Fournier KF, Mansfield P, Badgwell BD. Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved. Ann Surg Oncol. e-Pub 2018. PMID: 29748883.
Uberoi AS, Badgwell BD, Bhutani MS. An Unusual Gastric Antral Mass. Gastroenterology 154(5):e16-e17, 2018. e-Pub 2018. PMID: 28807844.
Ikoma N, Cloyd J, Badgwell BD, Agnes A, Rodriguez-Bigas M, Ajani JA, You YN. Clinical Features and Survival of Gastric Cancer Patients with DNA Mismatch Repair Deficiency. J Surg Oncol 117(4):707-709, 2018. e-Pub 2018. PMID: 29228462.
Fisher SB, Rafeeq S, Hess K, Grotz TE, Mansfield P, Royal R, Badgwell B, Fleming J, Fournier K, Mann GN. Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). J Surg Oncol 117(4):685-691, 2018. e-Pub 2018. PMID: 29193085.
Ikoma N, Cormier JN, Feig B, Du XL, Yamal JM, Hofstetter W, Das P, Ajani JA, Roland CL, Fournier K, Royal R, Mansfield P, Badgwell BD. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. Cancer 1(24/5):998-1007, 2018. e-Pub 2018. PMID: 29393964.
Mizrak Kaya D, Nogueras-González GM, Harada K, Amlashi FG, Roy-Chowdhuri S, Estrella JS, Das P, Lee JH, Weston B, Bhutani MS, Jr MA, Thomas I, Lin Q, Badgwell BD, Ajani JA. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma. J Surg Oncol 117(4):678-684, 2018. e-Pub 2018. PMID: 29205363.
Ikoma N, Blum M, Estrella JS, Das P, Hofstetter WL, Fournier KF, Mansfield P, Ajani JA, Badgwell BD. Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy. Gastric Cancer 21(1):74-83, 2018. e-Pub 2018. PMID: 28643144.
Ajani JA, Estrella JS, Chen Q, Correa AM, Ma L, Scott AW, Jin J, Liu B, Xie M, Sudo K, Shiozaki H, Badgwell B, Weston B, Lee JH, Bhutani MS, Onodera H, Suzuki K, Suzuki A, Ding S, Hofstetter WL, Johnson RL, Bresalier RS, Song S. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors. Br J Cancer 118(1):52-61, 2018. e-Pub 2018. PMID: 29136404.
Badgwell B, Blum M, Das P, Estrella J, Wang X, Fournier K, Royal R, Mansfield P, Ajani J. Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer. Surg Endosc 32(1):512, 2018. e-Pub 2018. PMID: 28643069.
Ikoma N, Lee JH, Bhutani MS, Ross WA, Weston B, Chiang YJ, Blum MA, Sagebiel T, Devine CE, Jr MA, Fournier K, Mansfield P, Ajani JA, Badgwell BD. Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonography. J Gastrointest Oncol 8(6):1009-1017, 2017. e-Pub 2017. PMID: 29299361.
Ikoma N, Das P, Blum M, Estrella JS, Devine CE, Wang X, Fournier K, Mansfield P, Minsky BD, Ajani J, Badgwell BD. Preoperative Chemoradiation Therapy Does Not Increase Risk of Anastomotic Leak in Patients With Gastric Cancer. Int J Radiat Oncol Biol Phys 11(99):660-666, 2017. e-Pub 2017.
Ikoma N, Blum M, Estrella JS, Wang X, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD. Left Gastric Artery Lymph Nodes Should Be Included in D1 Lymph Node Dissection in Gastric Cancer. J Gastrointest Surg 21(10):1563-1570, 2017. e-Pub 2017. PMID: 28819789.
Mizrak Kaya D, Wang X, Harada K, Blum Murphy MA, Das P, Minsky BD, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Jr MA, Sagebiel T, Wu CC, Rogers JE, Thomas I, Maru DM, Skinner HD, Badgwell BD, Hofstetter WL, Ajani JA. 101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy. Onvology 93(4):243-248, 2017. e-Pub 2017. PMID: 28683449.
Badgwell B, Blum M, Das P, Estrella J, Wang X, Ho L, Fournier K, Royal R, Mansfield P, Ajani J. Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma. Ann Surg Oncol 24(11):3338-3344, 2017. e-Pub 2017. PMID: 28799004.
Ikoma N, Chen HC, Wang X, Blum M, Estrella JS, Fournier K, Mansfield P, Ajani J, Badgwell BD. Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy. Ann Surg Oncol 24(09):2679-2687, 2017. e-Pub 2017. PMID: 28332034.
Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA. Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer. Int J Gynecol Cancer 27(7):1350-1359, 2017. e-Pub 2017. PMID: 28574929.
Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mares J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Jr MA, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma. Ann Surg Oncol 24(8):2291-2301, 2017. e-Pub 2017. PMID: 27770339.
Pujara D, Chiang YJ, Cormier JN, Bruera E, Badgwell B. Selective Approach for Patients with Advanced Malignancy and Gastrointestinal Obstruction. J Am Coll Surg 225(1):53-59, 2017. e-Pub 2017. PMID: 28483604.
Elimova E, Slack RS, Chen HC, Planjery V, Shiozaki H, Shimodaira Y, Charalampakis N, Lin Q, Harada K, Wadhwa R, Estrella JS, Kaya DM, Sagebiel T, Lee JH, Weston B, Bhutani M, Murphy MB, Matamoros A, Minsky B, Das P, Mansfield PF, Badgwell BD, Ajani JA. Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance. Oncotarget 08(45):81430-81440, 2017. e-Pub 2017. PMID: 29113402.
Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani J, Badgwell BD. Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer. Ann Surg Oncol 24(4):960-965, 2017. e-Pub 2017. PMID: 27778127.
Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani JA, Badgwell BD. Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer. Ann Surg Oncol 23(13):4332-4337, 2016. e-Pub 2016. PMID: 27384751.
Santos D, Chiang YJ, Badgwell B. Appendicitis in Cancer Patients Is Often Observed and Can Represent Appendiceal Malignancy. Am Surg 82(10):1028-1032, 2016. e-Pub 2016. PMID: 27779999.
Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani JA, Badgwell BD. Survival rates in T1 and T2 gastric cancer: A Western report. J Surg Oncol 114(5):602-606, 2016. e-Pub 2016. PMID: 27439746.
Al-Shamsi HO, Fahmawi Y, Dahbour I, Tabash A, Rogers JE, Mares JE, Blum MA, Estrella J, Jr MA, Sagebiel T, Devine CE, Badgwell BD, Lin QD, Das P, Ajani JA. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience. J Gastrointest Oncol 7(4):499-505, 2016. e-Pub 2016. PMID: 27563438.
Badgwell B, Blum M, Elimova E, Estrella J, Chiang YJ, Das P, Mansfield P, Ajani J. Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma. Ann Surg Oncol 23(6):1948-1955, 2016. e-Pub 2016. PMID: 26868957.
Charalampakis N, Nogueras González GM, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Rogers JE, Harada K, Jr MA, Sagebiel T, Das P, Minsky BD, Lee JH, Weston B, Bhutani MS, Estrella JS, Badgwell BD, Ajani JA. The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation. Oncology 90(5):239-47. e-Pub 2016. PMID: 27046280.
Kneuertz PJ, Hofstetter WL, Chiang YJ, Das P, Blum M, Elimova E, Mansfield P, Ajani J, Badgwell B. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?. Ann Surg Oncol 23(2):626-32, 2016. e-Pub 2016. PMID: 26564243.
Shiozaki H, Elimova E, Slack RS, Chen HC, Staerkel GA, Sneige N, Shimodaira Y, Sagebiel T, Lee JH, Bhutani MS, Das P, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases. J Surg Oncol 113(1):29-35, 2016. e-Pub 2016. PMID: 26603684.
Badgwell B, Ajani J, Blum M, Ho L, Fournier K, Chiang YJ, Matamoros A, Das P, Mansfield P. Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy. Ann Surg Oncol 23(1):156-61, 2016. e-Pub 2016. PMID: 26059652.
Day RW, Badgwell BD, Fournier KF, Mansfield PF, Aloia TA. Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy. J Gastrointest Surg 20(1):146-53, 2016. e-Pub 2016. PMID: 26416411.
Shiozaki H, Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Jr MA, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak Kaya D, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JA. Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors. Oncology 99(1):55-60, 2016. e-Pub 2016. PMID: 27120436.
Pujara D, Mansfield P, Ajani J, Blum M, Elimova E, Chiang YJ, Das P, Badgwell B. Comprehensive geriatric assessment in patients with gastric and gastroesophageal adenocarcinoma undergoing gastrectomy. J. Surg Onc 112(8):883-7, 2015. e-Pub 2015. PMID: 26482869.
Badgwell B, Blum M, Estrella J, Chiang YJ, Das P, Matamoros A, Fournier K, Mansfield P, Ajani J. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy. J Am Coll Surg 221(1):83-90, 2015. e-Pub 2015. PMID: 26002780.
Badgwell B, Roy-Chowdhuri S, Chiang YJ, Matamoros A, Blum M, Fournier K, Mansfield P, Ajani J. Long term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery. Journal of Surgical Oncology 117(7):875-81, 2015. e-Pub 2015. PMID: 25872485.
Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Jr MA, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively. Oncology 89(6):305-10, 2015. e-Pub 2015. PMID: 26393501.
Elimova E, Shiozaki H, Slack RS, Chen HC, Wadhwa R, Sudo K, Charalampakis N, Hiremath A, Estrella JS, Matamoros A, Sagebiel T, Das P, Rogers JE, Garris JL, Blum MA, Badgwell B, Ajani JA. Early versus Delayed Therapy of Advanced Gastric Cancer Patients - Does It Make a Difference?. Oncology 89(4):215-20, 2015. e-Pub 2015. PMID: 26159599.
Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg VS. Axillary reverse mapping: Five-year experience. Surgery 156(5):1261-8, 2014. e-Pub 2014. PMID: 25444319.
Badgwell B, Bruera E, Klimberg SV. Can Patient Reported Outcomes Help Identify the Optimal Outcome in Palliative Surgery?. Journal of Surgical Oncology 109(2):145-50, 2014. e-Pub 2014.
Badgwell B, Krouse R, Klimberg SV, Bruera E. Outcome Measures Other than Morbidity and Mortality for Patients with Incurable Cancer and Gastrointestinal Obstruction. Journal of Palliative Medicine 17(1):18-26, 2014. e-Pub 2014. PMID: 24341323.
Owens P, Henry-Tillman R, Badgwell B. Predictors of stage and the application of curative-intent surgery in pancreatic cancer: a population-based analysis from the Arkansas Cancer Registry. The Journal of the Arkansas Medical Society 110(2):43-45, 2013. e-Pub 2013. PMID: 24015448.
Badgwell B, Stanley J, Chang GJ, Katz MH, Lin HY, Ning J, Klimberg SV, Cormier JN. Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery. Journal of Surgical Oncology 108(3):182-6, 2013. e-Pub 2013. PMID: 23804149.
Badgwell BD, Aloia TA, Garrett J, Chedister G, Miner T, Krouse R. Indicators of symptom improvement and survival in inpatients with advanced cancer undergoing palliative surgical consultation. J Surg Oncol 107(4):367-71, 2013. e-Pub 2013. PMID: 22886727.
Collins LK, Goodwin JA, Spencer HJ, Guevara C, Ferrell B, McSweeney J, Badgwell BD. Patient reasoning in palliative surgical oncology. J Surg Oncol 107(4):372-5, 2013. e-Pub 2013. PMID: 22806710.
Badgwell B, Krouse R, Cormier J, Guevara C, Klimberg VS, Ferrell B. Frequent and early death limits quality of life assessment in patients with advanced malignancies evaluated for palliative surgical intervention. Ann Surg Oncol 19(12):3651-8, 2012. e-Pub 2012. PMID: 22669450.
Boneti C, Badgwell B, Robertson Y, Korourian S, Adkins L, Klimberg V. Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy. Minerva Ginecol 64(5):421-30, 2012. e-Pub 2012. PMID: 23018481.
Wilson M, Korourian S, Boneti C, Adkins L, Badgwell B, Lee J, Suzanne Klimberg V. Long-term results of excision followed by radiofrequency ablation as the sole means of local therapy for breast cancer. Ann Surg Oncol 19(10):3192-8, 2012. e-Pub 2012. PMID: 22911363.
Garrett J, Klimberg VS, Anaissie E, Barlogie B, Turnage R, Badgwell BD. The surgical management of abdominal pain in the multiple myeloma patient. Am J Surg 203(2):127-31, 2012. e-Pub 2012. PMID: 21788006.
Byrum S, Avaritt NL, Mackintosh SG, Munkberg JM, Badgwell BD, Cheung WL, Tackett AJ. A quantitative proteomic analysis of FFPE melanoma. J Cutan Pathol 38(11):933-6, 2011. e-Pub 2011. PMID: 21883366.
Johnson CB, Korourian S, Badgwell BD, Fincher RL, Dell CM, Don Bice C, Boneti C, Westbrook KC, Klimberg VS. Sensitivity of axillary specimen x-ray to predict nodal count and positivity. Ann Surg Oncol 18(11):3181-6, 2011. e-Pub 2011. PMID: 21861231.
Klimberg VS, Boneti C, Adkins LL, Smith M, Siegel E, Zharov V, Ferguson S, Henry-Tillman R, Badgwell B, Korourian S. Feasibility of percutaneous excision followed by ablation for local control in breast cancer. Ann Surg Oncol 18(11):3079-87, 2011. e-Pub 2011. PMID: 21904959.
Badgwell BD, Contreras C, Askew R, Krouse R, Feig B, Cormier JN. Radiographic and clinical factors associated with improved outcomes in advanced cancer patients with bowel obstruction. J Palliat Med 14(9):990-6, 2011. e-Pub 2011. PMID: 21767166.
Brouquet A, Vauthey JN, Badgwell BD, Loyer EM, Kaur H, Curley SA, Abdalla EK. Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg 98(7):1003-9, 2011. e-Pub 2011. PMID: 21541936.
Badgwell BD, Pierce C, Broadwater JR, Westbrook K, Korourian S, Davis D, Hiatt K, Lee J, Cheung WL, Klimberg VS. Intraoperative sentinel lymph node analysis in melanoma. J Surg Oncol 103(1):1-5, 2011. e-Pub 2011. PMID: 21165982.
Badgwell BD, Chang GJ, Rodriguez-Bigas MA, Smith K, Lupo PJ, Frankowski RF, Delclos G, Du XL, Cormier J. Management and outcomes of anorectal infection in the cancer patient. Ann Surg Oncol 16(10):2752-8, 2009. e-Pub 2009. PMID: 19649556.
Badgwell B D, Smith K, Liu P, Bruera E, Curley SA, Cormier JN. Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation. Support Care Cancer 17(6):727-34, 2009. e-Pub 2009. PMID: 19083026.
Xing Y, Badgwell BD, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN. Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer 115(11):2505-13, 2009. e-Pub 2009. PMID: 19309746.
Badgwell B, Cormier JN, Xing Y, Yao J, Bose D, Krishnan S, Pisters P, Feig B, Mansfield P. Attempted salvage resection for recurrent gastric or gastroesophageal cancer. Ann Surg Oncol 16(1):42-50, 2009. e-Pub 2009. PMID: 18985270.
Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, Pisters PW, Feig B, Mansfield P. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?. Ann Surg Oncol 15(10):2684-91, 2008. e-Pub 2008. PMID: 18649106.
Badgwell BD, Cormier JN, Wray CJ, Borthakur G, Qiao W, Rolston KV, Pollock RE. Challenges in surgical management of abdominal pain in the neutropenic cancer patient. Ann Surg 248(1):104-9, 2008. e-Pub 2008. PMID: 18580213.
Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482-8, 2008. e-Pub 2008. PMID: 18427152.
Kim MM, Mansfield PF, Das P, Janjan NA, Badgwell BD, Phan AT, Delclos ME, Maru D, Ajani JA, Crane CH, Krishnan S. Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery. Int J Radiat Oncol Biol Phys 71(1):167-72, 2008. e-Pub 2008. PMID: 18406886.
Badgwell B, Feig BW, Ross MI, Mansfield PF, Wen S, Chang GJ. Pneumoperitoneum in the cancer patient. Ann Surg Oncol 14(11):3141-7, 2007. e-Pub 2007. PMID: 17680315.
Badgwell B, Xing Y, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Ann Surg Oncol 14(10):2867-75, 2007. e-Pub 2007. PMID: 17671814.
Lesinski GB, Badgwell B, Zimmerer J, Crespin T, Hu Y, Abood G, Carson WE. IL-12 pretreatments enhance IFN-alpha-induced Janus kinase-STAT signaling and potentiate the antitumor effects of IFN-alpha in a murine model of malignant melanoma. J Immunol 172(12):7368-76, 2004. e-Pub 2004. PMID: 15187113.
Badgwell B, Lesinski GB, Magro C, Abood G, Skaf A, Carson W. The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line. J Surg Res 116(1):129-36, 2004. e-Pub 2004. PMID: 14732359.
Lesinski GB, Anghelina M, Zimmerer J, Bakalakos T, Badgwell B, Parihar R, Hu Y, Becknell B, Abood G, Chaudhury AR, Magro C, Durbin J, Carson WE. The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest 112(2):170-80, 2003. e-Pub 2003. PMID: 12865406.
Badgwell BD, Povoski SP, Abdessalam SF, Young DC, Farrar WB, Walker MJ, Yee LD, Zervos EE, Carson WE, Burak WE. Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 10(4):376-80, 2003. e-Pub 2003. PMID: 12734085.
Badgwell BD, Valentino DJ, Jeffes EB, Dieffenbach K, Dulkanchainun SB, Yamamoto RS, Granger GA, Jakowatz JG, Carson WE. Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma. Cancer Immunology Immunotherapy 52(1):10-6, 2003. e-Pub 2003. PMID: 12536235.
Badgwell B, Valentino D, Jeffes EWB, Dieffenback K, Dulkanchainun SB, Yamamoto R, Granger G, Kakowatz J, Carson W. Increased Efficacy of Intra-arterial over Intravenous Infusions of Recombinant TNF Alpha into Extremity-Localized R3230 Rat Mammary Adenocarcinomas. Cancer Immunology Immunoherapy 52(1):10-16, 2003. e-Pub 2003.
Badgwell BD, Parihar R, Magro C, Dierksheide J, Russo T, Carson WE. Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery 132(2):205-12, 2002. e-Pub 2002. PMID: 12219013.
Zervos EE, Badgwell BD, Burak WE, Arnold MW, Martin EW. Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup. Surgery 130(4):636-43; discussion 643-4, 2001. e-Pub 2001. PMID: 11602894.
Zervos EE, Badgwell BD, Abdessalam SF, Farrar WB, Walker MJ, Yee LD, Burak WE. Selective analysis of the sentinel node in breast cancer. Am J Surg 182(4):372-6, 2001. e-Pub 2001. PMID: 11720674.

Invited Articles

White MG, Badgwell B. Oncologic Components of HIPEC: Key Question : In patients with gastric or colorectal adenocarcinoma metastatic to the peritoneum, does cytoreductive surgery (CRS) plus hyperthermic intraperitoneal perfusion with chemotherapy (HIPEC) prolong survival or increase the risk of complications relative to CRS alone?. Ann Surg Oncol 29(11):6561-6564, 2022. e-Pub 2022. PMID: 34994900.
B B. Regional therapy trials in peritoneal metastases: The path to standardization of care for gastric cancer. J Surg Oncol 125(1):64-68, 2022. e-Pub 2022. PMID: 34897716.
Shi C, Badgwell BD, Grabsch HI, Gibson MK, Hong SM, Kumarasinghe P, Lam AK, Lauwers G, O’Donovan M, van der Post RS, Tang L, Ushiku T, Vieth M, Selinger CI, Webster F, Nagtegaal ID. Data Set for Reporting Carcinoma of the Stomach in Gastrectomy. Arch Pathol Lab Med, 2021. e-Pub 2021. PMID: 34919649.
White MG, Badgwell B. Laparoscopic Heated Intraperitoneal Chemotherapy in the Treatment of Carcinomatosis of Gastric Adenocarcinoma Origin. J Clin Med 10(20), 2021. e-Pub 2021. PMID: 34682880.
Joshi SS, Badgwell B. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. e-Pub 2021. PMID: 33592120.
Allen CJ, BD B. ASO Author Reflections: Do Advances in Neoadjuvant Therapy Influence How We Surgically Manage the Regional Lymphatics in Gastric Cancer?. Ann Surg Onc 27(2):543-544, 2020. e-Pub 2020. PMID: 31650303.
Newhook TE, Badgwell BD. ASO Author Reflections: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Patients with Metastatic Gastric Cancer. Ann Surg Oncol 26((Supp 3)):606-607, 2019. e-Pub 2019. PMID: 31069555.
Stark AP, Ikoma N, Badgwell BD. ASO Author Reflections: In Gastric Cancer Patients with Primary Tumor Pathologic Complete Response, Treatment-Refractory Nodal Disease is an Ominous Sign. Ann Surg Oncol 26((Suppl 3)):819-820, 2019. e-Pub 2019. PMID: 31667726.
Hodge C, Badgwell BD. Palliation of malignant ascites (Review). J Surg Oncol 120(1):67-73, 2019. e-Pub 2019. PMID: 30903617.
Vicente D, Ikoma N, Badgwell BD. ASO Author Reflections: Survival Impacts of Therapy and Complications in Gastric Adenocarcinoma. Ann Surg Oncol(Suppl 3):753-754, 2018. e-Pub 2018. PMID: 30374929.
Ikoma N, Badgwell BD. ASCO Author Reflections: Nodal Downstaging in Gastric Cancer. Ann Surg Oncology(Suppl 3):751-752, 2018. e-Pub 2018. PMID: 30353393.
Harada K, Lopez A, Shanbhag N, Badgwell B, Baba H, Ajani J. Recent advances in the management of gastric adenocarcinoma patients (Review). F1000Res 30:7. e-Pub 2018. PMID: 30228868.
Badgwell B, Das P, Ajani J. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol 10(1):149, 2017. e-Pub 2017. PMID: 28810883.
Agnes A, Estrella JS, Badgwell B. The significance of a nineteenth century definition in the era of genomics: linitis plastica. World J Surg Oncol 15(1):123, 2017. e-Pub 2017. PMID: 28679451.
Ikoma N, Badgwell BD, Mansfield PF. Multimodality Treatment of Gastric Lymphoma. Surg Clin North Am 97(2):405-420, 2017. e-Pub 2017. PMID: 28325194.
Badgwell B. Multimodality Therapy of Localized Gastric Adenocarcinoma (Review). J Natl Compr Canc Netw 14(10):1321-1327, 2016. e-Pub 2016. PMID: 27697984.
Shiozaki H, Shimodaira Y, Elimova E, Wadhwa R, Sudo K, Harada K, Estrella JS, Das P, Badgwell B, Ajani JA. Evolution of gastric surgery techniques and outcomes. Chin J Cancer 35(1), 2016. e-Pub 2016. PMID: 27460019.
Elimova E, Wadhwa R, Shiozaki H, Sudo K, Estrella JS, Badgwell BD, Das P, Jr MA, Song S, Ajani JA. Molecular biomarkers in gastric cancer. J Natl Compr Canc Netw 13(4):19-29, 2015. e-Pub 2015. PMID: 26052595.
Elimova E, Shiozaki H, Wadhwa R, Sudo K, Chen Q, Estrella JS, Blum MA, Badgwell B, Das P, Song S, Ajani JA. Medical Management of Gastric Cancer: a 2014 update. World Journal of Gastroenterology 20(38):13637-47, 2014. e-Pub 2014. PMID: 25320502.
Badgwell B, Chang G. Lymph Node Evaluation and Survival in Stage II and III Colon Cancer. Seminars in Colon & Rectal Surgery 19(1):26-29, 2011. e-Pub 2011.
Badgwell B, Chang G. Evidence for Improved Survival with Increased Lymph Node Evaluation in Stage II and III Colon Cancer. American Journal of Hematology and Oncology 6(11):631-633, 2007. e-Pub 2007.
Badgwell B, Ellison EC. Klatskin's tumor: is there new hope?. Curr Surg 57(6):570-573, 2000. e-Pub 2000. PMID: 11120299.

Review Articles

Kim HI, Badgwell BD. Peritoneal Oligometastasis in Gastric Cancer: Diagnostic Strategies, Patient Selection, and Emerging Therapeutic Approaches. J Gastric Cancer 25(3):409-423, 2025. e-Pub 2025. PMID: 40631471.
Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL, Olecki E, Radomski SN, Sun B, Turaga KK, Gunderson CG, Lacy J, Badgwell BD, In H, Kennedy T, Yoon HH, Greer JB, Sundar R, Woo Y. Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 40560499.
Lewis KA, Diggs LP, Badgwell BD. Educational Review: Updates on Therapeutic Strategies for Gastric Cancer with Peritoneal Metastasis. Ann Surg Oncol 32(5):3672-3687, 2025. e-Pub 2025. PMID: 40016614.
Jain AJ, Badgwell BD. Current Evidence for the Use of HIPEC and Cytoreductive Surgery in Gastric Cancer Metastatic to the Peritoneum. J Clin Med 12(20), 2023. e-Pub 2023. PMID: 37892663.
Badgwell BD, Camp ER, Feig B, Wolff RA, Eng C, Ellis LM, Cormier JN. Management of bevacizumab-associated bowel perforation: a case series and review of the literature. Ann Oncol 19(3):577-82, 2008. e-Pub 2008. PMID: 18024857.

Editorials

Badgwell BD, Ajani J. Is Surgery Still the Only Known Cure for Gastric Cancer?. Ann Surg Oncol 31(13):8494-8495, 2024. PMID: 39354246.
Badgwell BD. Multidisciplinary Care: How to Win Friends and Influence Your Colleagues to Provide Quality Goals-of-Care Discussions. Ann Surg Oncol. PMID: 37723357.
Badgwell BD. Don't Call It a Comeback-HIPEC for Gastric Cancer. Ann Surg Oncol 29(12):7244-7245, 2022. PMID: 35939170.
B B. Is PIPAC a New Summit for Peritoneal Disease Treatment or are we Lost in the Snowstorm?. Annals of Surgical Oncology 29(1):13-14, 2022. PMID: 34642846.
Badgwell B. Everything, in Retrospect, is Obvious. Ann Surg Oncol 28(7):3457-3458, 2021. PMID: 33755829.
Badgwell B. Will Palliative Care Ever Be Cool?. Ann Surg Oncol. PMID: 29748888.
Badgwell B, Blum M, Estrella J, Ajani J. Personalised therapy for localised gastric and gastro-oesophageal adenocarcinoma. Lancet Oncol 17(12):1628-1629, 2016. PMID: 27776842.
Elimova E, Badgwell B, Das P, Estrella J, Matamoros A, Ajani J. How do we treat patients with gastric cancer?. Oncology Times 36(16), 2014.

Abstracts

Badgwell B, Ikoma N, Blum Murphy M, Wang X, Estrella J, Roy-Chowdhuri S, Das P, Minsky B, Lano E, Song S, Mansfield P, Ajani J. A Phase II Trial of Cytoreduction, Gastrectomy, and HIPEC for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology. A Phase II Trial of Cytoreduction, Gastrectomy, and HIPEC for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology, 2020. e-Pub 2020.
White M, Kothari A, Ikoma N, Blum Murphy M, Song S, Ajani J, Mansfield P, B B. Should Ascites be a Contraindication to Laparoscopic HIPEC in Gastric Cancer?. Society of Surgical Oncology Advanced Cancer Therapies, 2020. e-Pub 2020.
Blumenthaler A, Allen C, Ikoma N, Blum M, Das P, Minsky B, Mansfield P, Ajani J, Badgwell B. Laparoscopic HIPEC for Low-volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma. Society of Surgical Oncology Advanced Cancer Therapies, 2020. e-Pub 2020.
Scally C, Robinson K, Bruera E, Badgwell B. Core Principles of Palliative Care Consultation for Surgical Oncology Patients. Western Surgical Association, Las Vegas, 2019. e-Pub 2019.
Davis C, Ikoma N, Blum M, Ajani J, Mansfield P, Badgwell B. Comparison of Laparoscopy versus Mini-Laparotomy for Jejunostomy Placement in Patients with Gastric Adenocarcinoma. . Scientific Forum, American College of Surgeons Clinical Congress, San Francisco, 2019. e-Pub 2019.
Badgwell, B, Blum, M, Ikoma, B, Wang, X, Estrella, J, Chodhuri, SR, Das, P, Minsky, B, Song, S, Mansfield, P, Ajani A, J. Phase I trial of hyperthermic intraperitoneal chemoperfusion (HIPEC) with cisplatin, mitomycin, and paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology. ASCO 2019 Annual Meeting, 2019. e-Pub 2019.
Badgwell B, Ikoma N, Das P, Minsky B, Blum M, Mansfield P, Ajani J. Long-term survival rates with preoperative chemoradiotherapy and gastrectomy in patients with gastric adenocarcinoma. 13th International Gastric Cancer Congress, 2019. e-Pub 2019.
Ikoma N, Estrella J, Blum M, Das P, Minsky B, Fournier K, Mansfield P, Badgwell B. Tumor Regression Grade in Gastric Cancer After Preoperative Therapy. Society of Surgical Oncology Annual Cancer Symposium, 2019. e-Pub 2019.
Allen CJ, Newhook T, Vreeland TJ, Das P, Minsky B, Blum M, Ajani J, Ikoma N, Mansfield P, Badgwell B. Prognostic Value of Lymph Node Yield Following Neoadjuvant Chemoradiation for Gastric Adenocarcinoma. Society of Surgical Oncology Annual Cancer Symposium, 2019. e-Pub 2019.
Allen CJ, Newhook T, Vreeland TJ, Das P, Minsky B, Blum M, Roy-Chowdhuri S, Ajani J, Ikoma N, Mansfield P, Badgwell B. Yield of Peritoneal Washings and Cytology in Staging Patients with Gastric and Gastroesophageal Cancer. Society of Surgical Oncology Annual Cancer Symposium, 2019. e-Pub 2019.
Newhook T, Allen CJ, Vreeland TJ, Ikoma N, Estrella J, Blum M, Das P, Minsky B, Mansfield P, Ajani J, Badgwell B. Impact of Perineural and Lymphovascular Invasion on Survival Following Gastrectomy for Gastric Cancer. Society of Surgical Oncology Annual Cancer Symposium, 2019. e-Pub 2019.
Allen J, Newhook T, Vreeland TJ, Das P, Minsky B, Blum M, Roy-Chowdhuri S, Ajani J, Ikoma N, Mansfield P, Badgwell B. Staging Laparoscopy and Peritoneal Cytology in Patients with Early Stage Gastric Adenocarcinoma. Society of Surgical Oncology Annual Cancer Symposium, 2019. e-Pub 2019.
Ikoma N, Estrella J, Hofstetter W, Ajani J, Mansfield K, Skibber J, Badgwell B. Surgeon Assessment of Gastric Cancer Lymph Node Specimens. 71st Society of Surgical Oncology Annual Cancer Symposium, 2018. e-Pub 2018.
Vicente D, Ikoma N, Chiang Y, Fournier K, Mansfield P, Ajani J, Badgwell B. Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy. 71st Society of Surgical Oncology Annual Cancer Symposium, 2018. e-Pub 2018.
Newhook T, Agnes A, Blum M, Estrella J, Chowdhuri SR, Matamoros A, Das P, LHo, Ajani J, Badgwell B. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy. 71st Society of Surgical Oncology Annual Cancer Symposium, 2018. e-Pub 2018.
Ikoma N, Estrella J, Hofstetter W, Das P, Ajani J, Fournier K, Mansfield P, Badgwell B. Nodal Downstaging in Gastric Cancer: Promising Survival if ypN0 is Achieved. 71st Society of Surgical Oncology Annual Cancer Symposium, 2018. e-Pub 2018.
Ikoma N, Estrella J, Hofstetter W, Das P, Ajani J, Fournier K, Mansfield P, Badgwell B. Nodal Downstaging in Gastric Cancer in Relation to Survival When ypN0 is Achieved. ASCO Gastrointestinal Cancers Symposium, 2018. e-Pub 2018.
Vicente D, Ikoma N, Chiang Y, Fournier K, Mansfield P, Ajani J, Badgwell B. Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy. ASCO Gastrointestinal Cancers Symposium, 2018. e-Pub 2018.
Ikoma N, Das P, Blum M, Estrella J, Devine C, Fournier K, Mansfield P, Minsky B, Ajani J, Badgwell B. Preoperative Chemoradiation Therapy Does Not Increase Risk of Anastomotic Leak in Patients with Gastric Cancer. Digestive Disease Week 99(3):660-666, 2017. e-Pub 2017. PMID: 29280460.
Ikoma N, Das P, Blum M, Estrella J, Chen H, Wang X, Fournier K, Mansfield P, Roland C, Cormier J, Ajani J, Badgwell B. Preoperative Chemoradiation Induces Primary Tumor Complete Response More Frequently Than Chemotherapy Alone in Gastric Cancer. Western Surgical Association, 2017. e-Pub 2017.
Ikoma N, Blum M, Estrella J, Fournier K, Mansfield P, Ajani J, Badgwell B. Left Gastric Artery Lymph Nodes Should be Included in D1 Lymph Node Dissection in Gastric Cancer. Digestive Disease Week, 2017. e-Pub 2017.
Badgwell B, Blum M, Das P, Estrella J, Wang X, Ho L, Fournier K, Royal R, Mansfield P, Ajani J. A phase II laparoscopic hyperthermic intraperitoneal chemoperfusion (HIPEC) for gastric carcinomatosis or positive cytology. Society of Surgical Oncology Annual Cancer Symposium, Beijing China, 2017. e-Pub 2017.
Ikoma N, Estrella J, Blum M, Chen H, Wang X, Fournier K, Mansfield P, Ajani J, Badgwell B. Impact of Central Lymph Node Examination in Gastric Cancer. Society of Surgical Oncology Annual Cancer Symposium, 2017. e-Pub 2017.
Badgwell B, Blum M, Das P, Estrella J, Wang X, Ho L, Fournier K, Royal R, Mansfield P, Ajani J. Video Presentation; Lessons Learned from a Phase II Clinical Trial of Laparoscopic hyperthermic intraperitoneal chemoperfusion (HIPEC) for Gastric Cancer. SAGES 2017 Annual Meeting, 2017. e-Pub 2017.
Ikoma N, Estrella J, Blum M, Chen HC, Wang X, Fournier K, Mansfield P, Ajana J, Badgwell B. Lymph node metastasis in gastric cancer: Location of positive station to predict survival after preoperative therapy. ASCO Gastrointestinal Cancers Symposium, Society of Surgical Oncology Annual Cancer Symposium, 2017. e-Pub 2017.
Ikoma N, Chen HC, Wang X, Blum M, Estrella J, Fournier K, Mansfield P, Ajani J, Badgwell B. Recurrence patterns of gastric cancer in the era of preoperative therapy. ASCO Gastrointestinal Cancers Symposium, 2017. e-Pub 2017.
Badgwell B, Purjara D, Chiang YJ, Cormier J. Bowel obstruction in advanced cancer patients: variables associated with outcome and survival. Western Surgical 2016 Annual Scientific Session, 2016. e-Pub 2016.
Badgwell B, Williams L, Bruera E. In search of the optimal outcome measure for patients with advanced cancer and gastrointestinal obstruction: a qualitative research study. ASCO Palliative Care in Oncology Symposium, 2016. e-Pub 2016.
Santos D, Badgwell B. Non-surgical management and interval cholecystectomy is preferred for acute cholecystitis in cancer patients. Society of Surgical Oncology Annual Cancer Symposium, 2016. e-Pub 2016.
Ikoma N, Elimova E, Blum M, Ajani J, Chiang YJ, Fournier K, Mansfield P, Badgwell B. Race is a risk factor for lymph node metastases in early T stage gastric cancer. Society of Surgical Oncology Annual Cancer Symposium, 2016. e-Pub 2016.
Badgwell B, Blum M, Das P, Elimova E, Mansfield P, Ajani J. A phase II study of laparoscopic hyperthermic intraperitoneal chemoperfusion (HIPEC) for gastric carcinomatosis or positive cytology. ASCO Gastrointestinal Cancers Symposium, 2016. e-Pub 2016.
Ikoma N, Elimova E, Blum M, Ajani J, Chiang YJ, Fournier K, Mansfield P, Badgwell B. Yield of staging laparoscopy in gastric cancer. ASCO Gastrointestinal Cancers Symposium, 2016. e-Pub 2016.
Ikoma N, Elimova E, Blum M, Ajani J, Chiang YJ, Fournier K, Mansfield P, Badgwell B. Risk factors for survival in early T stage gastric cancer. ASCO Gastrointestinal Cancers Symposium, 2016. e-Pub 2016.
Ikoma N, Elimova E, Blum M, Ajani J, Chiang YJ, Fournier K, Mansfield P, Badgwell B. Preoperative accuracy of gastric cancer staging in patient selection for neoadjuvant therapy. ASCO Gastrointestinal Cancers Symposium, 2016. e-Pub 2016.
Kneuertz P, Hofstetter W, Chiang Y, Das P, Blum M, Fournier K, Mansfield P, Ajani J, Badgwell B. Long-term survival in patients with gastroesophageal junction cancer treated with neoadjuvant therapy: Do thoracic and abdominal approaches differ?. Society of Surgical Oncology Annual Cancer Symposium, 2015. e-Pub 2015.
Badgwell B, Blum M, Estrella J, Chiang Y, Das P, Mansfield P, Fournier K, Ajani J. Predictors of survival in patients with resectable gastric cancer treated with neoadjuvant chemoradiation therapy and gastrectomy. Western Surgical Association Annual Scientific Session, 2014. e-Pub 2014.
Tseng W, Cormier J, Badgwell B. Comprehensive outcomes assessment in patients with incurable cancer and small bowel obstruction. Society of Surgical Oncology Annual Cancer Symposium, 2014. e-Pub 2014.
Stanley J, Badgwell B. Comprehensive geriatric assessment in cancer patients undergoing abdominal surgery. Academic Surgical Congress, 2013. e-Pub 2013.
Garrett J, Badgwell B, Chedister G, Miner T, Krouse R. Indicators of symptom improvement and survival in inpatients with advanced cancer undergoing palliative surgical consultation. UAMS Student Research Day, 2012. e-Pub 2012.
Collins L, Goodwin J, Guevara C, Ferrell B, McSweeney J, Badgwell B. Patient reasoning in palliative surgical oncology. Academic Surgical Congress, 2012. e-Pub 2012.
Badgwell B, Contreras C, Askew R, Krouse R, Feig B, Cormier J. Radiographic and clinical factors associated with diminished outcomes in advanced cancer patients with bowel obstruction. Academic Surgical Congress, 2011. e-Pub 2011.
Garrett J, Klimberg S, Turnage R, Badgwell B. Challenges in the surgical management of abdominal pain in the myeloma patient. UAMS Student Research Day, April 2010, & American College of Surgeons 96th Annual Clinical Congress, 2010. e-Pub 2010.
Pierce C, Broadwater R, Westbrook K, Korourian S, Davis D, Hiatt K, Lee J, Klimberg S, Badgwell B. Intraoperative sentinel lymph node analysis in melanoma. Society of Surgical Oncology, 2010. e-Pub 2010.
McAuliffe P, Gershenwald J, Lee J, Badgwell B, Ballo M, Cormier J, Mansfield P, Chang G, Zagars G, Camp E, Ross M. Role of Sentinel Lymph Node Biopsy in Anorectal Melanoma. Society of Surgical Oncology, 2010. e-Pub 2010.
Klimberg V, Badgwell B, Adkins L, Smith M, Korourian S. Can We Eliminate Radiotherapy After Breast Conservation Therapy? Results Of A Phase II Trial of eRFA. Society of Surgical Oncology, 2009. e-Pub 2009.
Bose D, Badgwell B, Cormier J, Wen S, Yao J, Staerkel G, Crane C, Pisters P, Phan A, Mansfield P. The Gastric Cancer Multidisciplinary Group. Association of neoadjuvant chemoradiation with improved survival in resectable gastric cancer. Gastrointestinal Cancer Symposium of the American Society of Clinical Oncology, 2009. e-Pub 2009.
Badgwell B, Smith K, Liu P, Bruera E, Curley S, Cormier J. Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation. Multinational Association of Supportive Care in Cancer Symposium, 2008. e-Pub 2008.
Badgwell B, Cormier J, Krishnan S, Yao J, Lupo P, Pisters P, Feig B, Mansfield P. Does Neoadjuvant Treatment for Patients with Positive Peritoneal Cytology at Staging Laparoscopy Improve Survival?. Society of Surgical Oncology, 2008. e-Pub 2008.
Badgwell B, Cormier J, Wray C, Borthakur G, Qiao W, Rolston K, Pollock R. Challenges in Surgical Management of Abdominal Pain in the Neutropenic Cancer Patient. Infections in Cancer Symposium, 2008. e-Pub 2008.
Badgwell B, Yao J, Bose D, Qiao W, Krishnan S, Pisters P, Feig B, Mansfield P. Attempted Salvage Resection for Recurrent Gastric or Gastroesophageal Cancer. Gastrointestinal Cancer Symposium of the American Society of Clinical Oncology, 2008. e-Pub 2008.
Badgwell B, Xing Y, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN. Pelvic Lymph Node Dissection Is Beneficial in Subsets of Patients with Node-positive Melanoma. American Society of Clinical Oncology, 2007. e-Pub 2007.
Badgwell B, Vauthey J, Ribero D, Curley SA, Abdalla EK. Resection of Hepatic Recurrence Following Radiofrequency Ablation for Liver Metastases. Seventh Americas Hepatobiliary Congress, 2007. e-Pub 2007.
Badgwell B, Feig B, Ross M, Mansfield P, Chang G. Pneumoperitoneum in the Cancer Patient. Gastrointestinal Cancer Symposium of the American Society of Clinical Oncology, 2007. e-Pub 2007.
Badgwell B, Melvin W, Needleman B. Roux-en-Y Gastric Bypass After Solid Organ Transplantation. Society American Gastrointestinal Endoscopic Surgeons, 2005. e-Pub 2005.
Badgwell B, Lesinski G, Magro C, Abood G, Skaf A, Carson AW. The Anti-Tumor Effects of Interferon-Alpha Are Maintained in Mice Challenged with a STAT1-Deficient Murine Melanoma Cell Line. Association of Academic Surgery, 2002. e-Pub 2002.
Badgwell B, Abood G, Hu Y, Carson W. Interleukin-12 Pre-treatments Increase Efficacy of Interferon-alpha in Melanoma. American College of Surgeons Ohio Chapter, 2002. e-Pub 2002.
Badgwell B, Abdessalam S, Farrar W, Carson W, Walker M, Yee L, Povoski S, Burak AW. Patterns of Recurrence Following Sentinel Lymph Node Biopsy for Breast Cancer. Society of Surgical Oncology, 2002. e-Pub 2002.
Badgwell B, Parihar R, Dierksheide J, Carson W. Natural Killer Cells Contribute to the Lethality of a Murine Model of E. Coli Infection. Society of University Surgeon, 2002. e-Pub 2002.
Badgwell B, Abood G, Hu Y, Carson W. Cytokine Combinations in the Treatment of Malignant Melanoma. Keystone Symposia, 2002. e-Pub 2002.
Badgwell B, Zervos E, Burak W, Arnold M, Martin E. FDG-PET as an Adjunct to CEA in the Management of Patients with Presumed Recurrent Colorectal Cancer and Normal Radiologic Workup. Sixth Annual Resident Research Conference, The Ohio State University, 2001. e-Pub 2001.
Badgwell B, Zervos E, Yee L, Walker M, Farrar W, Burak W. Selective Sentinel Node Analysis in Breast Cancer: The Potential for Resource Savings. American Society of Breast Surgeons, 2001. e-Pub 2001.
Badgwell B, Kuehl T. Pregnancy and Multiple Gestations from Intrauterine Insemination with and without Ovarian Stimulation. Texas A&M University Health Science Center Research Symposium, 1998. e-Pub 1998.

Book Chapters

Krouse R, Badgwell B. The role of general surgery in the palliative care of patients with cancer. In: Oxford Textbook of Palliative Medicine. 6th. Oxford University, 1093, 2021.
Hodge C, Badgwell. Palliative Surgery. In: Oncologic Emergency Medicine. 2nd. Springer Nature, 797-807, 2021.
Newhook T, Badgwell B. Minimally Invasive Hyperthermic Intraperitoneal Perfusion for Gastric Cancer. In: Minimally Invasive Surgical Techniques for Cancers of the Gastrointestinal Tract. 2nd. Springer, 93-99, 2019.
Badgwell B. Palliative Gastrointestinal Surgery. In: Surgical Palliative Care. Oxford University Press, 175-182, 2019.
Kim MP, Badgwell BD. Pancreatic Neuroendocrine Tumors. In: Fischer’s Mastery of Surgery 7th Edition. 7. Wolters Kluwer, 583-592, 2018.
Badgwell B. Surgical Emergencies. In: The MD Anderson Surgical Oncology Handbook, 2018.
Badgwell B. Gastric Cancer. In: The MD Anderson Surgical Oncology Handbook, 2018.
Badgwell B, Krouse R. Surgical Emergencies in the Palliative Care Patient. In: Surgical Emergencies in the Cancer Patient. Springer International Publishing, 397-405, 2017.
Badgwell B. Principles of Palliative Care for Patients with Pancreatic Cancer. In: Textbook of Complex General Surgical Oncology. McGraw-Hill Professional Publishing, 2017.
Ismael H, Badgwell B. Palliative Operations for Unresectable Pancreatic Cancer. In: Multimodality Management of Borderline Resectable Pancreatic Cancer. Springer International Publishing, 319-328, 2016.
Badgwell B. Palliative Surgery. In: Oncologic Emergency Medicine. Springer International Publishing, 483-92, 2016.
Clark C, Badgwell B. Open Distal Gastrectomy. In: Surgery for Cancers of the Gastrointestinal Tract. Springer, 65-74, 2015.
Badgwell B, Mansfield P. Open methods of resection and reconstruction for subtotal and total gastrectomy. In: Gastric Cancer – Principles and Practice. Springer International Publishing, 199-209, 2015.
Badgwell B, Krouse R. The role of general surgery in the palliative care of patients with cancer. In: Oxford Textbook of Palliative Medicine. 5th. Oxford University, 790-8, 2015.
Badgwell B, Day R, Aloia T. Managing early and late postoperative complications following gastric surgery. In: Gastric Cancer – Principles and Practice. Springer International Publishing, 239-249, 2015.
Badgwell B, Turnage R. Abdominal Wall, Umbilicus, Peritoneum, Mesentery, Omentum, and Retroperitoneum. In: Sabiston Textbook of Surgery. 19th. Elsevier Saunders, 1088-113, 2013.
Badgwell B. Oncologic Emergencies. In: The M. D. Anderson Surgical Oncology Handbook. Lippincott Williams & Wilkins, 764-777, 2012.
Badgwell B, Feig BW. Abdominal Emergencies in Cancer Patients: Diagnosis and Management. In: When Cancer Crosses Disciplines: A Physician’s Handbook. Imperial College Press, 421-437, 2010.
Badgwell B, Ribero D, Vauthey JN. Surgical Management (Resection) of Hepatocellular Carcinoma. In: Interventional Oncology: Principles and Practice. Cambridge University Press, 2008.
Badgwell B, Muscarella P, Ellison EC. Pancreatic Endocrine Tumors. In: Pocket Surgical Oncology, 2001.

Letters to the Editor

Kapoor R, Robinson K, Badgwell B. Nephrotoxic synergism of cisplatin and mitomycin-C for hyperthermic intraperitoneal chemotherapy and cytoreductive surgery. International Journal of Hyperthermia 34: 601, 2018.

Less

CV information above last modified February 11, 2026

Brian D. Badgwell, MD

About Dr. Badgwell

Present Title & Affiliation

Primary Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Other Articles

Editorials

Abstracts

Book Chapters

Letters to the Editor

Patient Reviews

Related Links

Stomach cancer

Gastrointestinal Cancer Center

Surgical Oncology Department

Surgery Division

Help #EndCancer

Brian D. Badgwell, MD

About Dr. Badgwell

Present Title & Affiliation

Primary Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Other Articles

Editorials

Abstracts

Book Chapters

Letters to the Editor

Patient Reviews

Request an Appointment

Related Links

Stomach cancer

Gastrointestinal Cancer Center

Surgical Oncology Department

Surgery Division

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop MD Anderson